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Abstract 
 
Both epidemiological and empirical data have demonstrated the association between 
long-term exposure to fine particulate matters (PM2.5) and the burden of atherosclerosis. 
Strawberry, a rich source of micronutrients and several bioactive phytochemicals, has 
been implicated in the prevention of cardiovascular diseases and metabolic syndromes. 
This study was designed to explore the effects of freeze-dried strawberry 
supplementation on PM2.5-potentiated atherosclerosis in apoE
-/-
 mice, which is a 
spontaneous atherosclerotic model. Mice, fed with high-fat chow or high-fat chow 
supplemented with 10% strawberry powder, were exposed to either filtered air or 
concentrated ambient particles using “Ohio Air Pollution Exposure Systems for 
Interrogation of Systemic Effects” for 6 months. After PM2.5 exposure, plaque area and 
lipid area of aorta were evaluated using hematoxylin & eosin staining and oil-red O 
staining, respectively. In addition, total cholesterol, high-density lipoprotein and fasting 
glucose were measured using diagnostic kits. Furthermore, the levels of inflammatory 
cytokines in plasma were determined via ELISA kits, and the mRNA expressions of 
inflammatory cytokines within lung were quantitated using real-time PCR. Our data 
showed that long-term PM2.5 exposure potentiated atherosclerosis and inflammation in 
these mice; strawberries reduced inflammation and improved lipid profile, but did not 
attenuate atherosclerosis after PM2.5 exposure. These findings indicate that other 
iii 
 
mechanistic pathways, e.g. systemic oxidative stress, autonomic nervous system 
imbalance, and the direct toxic effects of particles, may diminish the effects of 
strawberries on PM2.5-potentiated atherosclerosis.  
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Chapter 1:  Introduction 
 
Atherosclerosis is a progressive disease characterized by the accumulation of lipids and 
fibrous plaque in the large arteries. Although the etiology of atherosclerosis is very 
complicated, numerous risk factors have been identified and can be grouped into factors 
with an important genetic component and those that are largely related to environment. 
Particulate matters (PM) air pollution poses the great risks to the development of 
atherosclerosis in human; experimental studies, particularly using genetic mouse model, 
reveal that systemic inflammation may play a central role in PM-mediated 
atherosclerosis. This study aimed to identify key inflammatory mediators that regulate the 
enhancement of atherosclerosis after PM exposure. In addition, this study was designed 
to evaluate the effects of strawberry, a natural anti-inflammatory fruit, on PM-potentiated 
atherosclerosis.  
Central Hypothesis: Strawberry supplementation can attenuate the development of 
atherosclerotic plaque and reduce inflammation after PM2.5 exposure in a mouse model. 
To test this hypothesis, we proposed three specific aims.  
Aim 1: To determine the concentration and compositions of PM2.5 used in our study. 
PM2.5 sample was collected using Teflon filters via the whole body exposure system 
“Ohio Air Pollution Exposure Systems for Interrogation of Systemic Effects”. The 
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concentration of PM2.5 was measured using a microbalance; PM2.5 was extracted from the 
filters and the extracts were then analyzed for trace elements using high-resolution 
inductively coupled plasma-mass spectrometry.  
Aim 2: To identify inflammatory mediators regulating the enhancement of 
atherosclerosis after PM2.5 exposure. ApoE
-/-
 mice, fed with high-fat chow, were 
exposed to either filtered air or concentrated PM2.5 for 6 months. Plaque area and lipid 
area were evaluated by morphological staining. Total cholesterol, high-density 
lipoprotein (HDL) and glucose were measured using diagnostic kits. The levels of plasma 
cytokines were determined via ELISA kits, and the mRNA expressions of cytokines 
within lungs were quantitated via real-time PCR. 
Aim 3: To evaluate the effects of strawberry supplementation on PM2.5-potentiated 
atherosclerosis. ApoE
-/-
 mice, fed with high-fat chow with or without strawberry 
powder, were exposed to either filtered air or concentrated PM2.5 for 6 months. After 
exposure, atherosclerotic plaque, lipid profile, and inflammatory cytokines were 
evaluated as described in aim 2. 
Taken together, our study can provide compelling evidence on the effects of strawberry 
on PM2.5-mediated atherosclerosis. In addition, the exposure data collected from this 
study are useful for government to compare local PM2.5 levels and may provide a new 
target for monitoring air pollution. 
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Chapter 2: Particulate Matter Air Pollution and Atherosclerosis: Mechanistic Insights 
 
Background 
Atherosclerosis, the primary cause of heart disease and stroke, is a progressive disease 
characterized by the accumulation of lipids and fibrous plaque in the large arteries. 
Although the etiology of atherosclerosis is very complicated, numerous risk factors have 
been identified and can be grouped into factors with an important genetic component and 
those that are largely related to environment. Genome-wide association studies in human 
have revealed dozens of discrete genetic loci that are associated with myocardial 
infarction, coronary artery disease and other circulating biomarkers related to 
atherosclerosis [1]. The availability of novel animal models accelerates the process of 
identifying the causal gene at each loci and elucidating the molecular and physiological 
mechanisms. Mice deficient in apolipoprotein E (apoE) or the low-density lipoprotein 
(LDL) receptor develop advanced atherosclerotic lesions and are the models most used in 
genetic and physiological studies [2]. Previous studies indicate that diet appear to be the 
most significant environmental factor for atherosclerosis [3]. High-fat or high-cholesterol 
diet is mostly required for development of atherosclerotic lesion in experimental animals 
[4, 5]. In addition, other environmental factors associated with atherosclerosis include 
smoking [6], lack of exercise [7], and infectious agents [8].  
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Particulate matter (PM) air pollution is a mixture of microscopic solid and liquids 
droplets suspended in air, consisting of numerous components, e.g. acids, organic 
chemicals, metals, solids or dust particles, and allergen. According to its aerodynamic 
diameter, PM is classified into coarse (10 to 2.5 μm; PM10), fine (< 2.5 μm; PM2.5), and 
ultrafine (<0.1 μm; PM0.1) particles. It has been suggested that PM fraction poses the 
great risks to the development of atherosclerosis in human (Table 1). Although PM10 and 
PM0.1 may have the capacity to induce atherosclerosis, few studies have focused on these 
size fractions. Most data to date have provided the consistent association of increased 
atherosclerotic risk with exposure to PM2.5. The present review integrates the current 
experimental evidence to discuss the mechanistic pathways whereby PM inhalation can 
promote atherosclerosis. 
Development of Atherosclerotic Plaque  
A normal artery consists of three distinct layers (Fig.1A). The intima, the innermost 
layer, is bounded by a monolayer of endothelial cells (ECs) and is supported by an 
internal elastic lamina. The ECs are in direct contact with the blood flow and serve as a 
selectively permeable barrier between blood and tissues. Massive extracellular connective 
tissue matrix, primarily proteoglycans and collagen, exists in the intima. The media, the 
middle layer, consists of smooth muscle cells (SMCs). The adventitia, the outer layer, 
consists of connective tissues with interspersed fibroblasts. Atherosclerotic lesion occurs 
in the intima and involves multiple cell types, e.g. monocytes, T cells, ECs and SMCs. 
The key events of atherosclerotic plaque development consist of lesion initiation, foam-
cell formation and fibrous plaque formation, which have been well clarified by animal 
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studies [9]. Lesion initiation is characterized by the disruption of vascular endothelial 
integrity and the accumulation of LDL in the extracellular matrix (Fig.1 B). The risk 
factors, including aging, genetic and environmental factors, may cause EC injury and 
change the lipid profile in circulation. For example, overexpression of human apoB in 
transgenic rabbits results in increased levels of LDL and decreased levels of high-density 
lipoprotein (HDL) [10]. After passing through EC junction, LDL tends to bind to the 
subendothelial extracellular matrix, a process known as LDL retention. The interactions 
between apoB, the ligand of LDL receptor, and matrix proteoglycans play an important 
role in LDL retention in the artery wall [11]. LDL in the intima undergoes the first 
oxidation to form minimally oxidized LDL. Injured ECs and 12/15-lipoxygenase may 
provide a source of reactive oxygen species (ROS) and seed the extracellular LDL 
through inserting molecular oxygen, respectively [12].  
HDL is strongly protective against atherosclerosis, although the beneficial effects remain 
elusive in particular patients, e.g. the patients with established coronary artery disease 
[13]. Several mechanisms may claim its protective effects. First, HDL can directly bind 
unesterified cholesterol and remove excess cholesterol from cells and extracellular tissues 
[14]. Second, HDL may reverse endothelial dysfunction and improve endothelial barrier 
integrity. Several in vitro studies have shown that treatment of ECs with HDL attenuate 
apoptosis in response to pro-atherogenic signals such as oxidized LDL [15], tumor 
necrosis factor [16], and growth factor deprivation [16]. Third, HDL carries an esterase 
known as serum paraoxonase that can degrade certain biologically active oxidized 
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phospholipids [17]. The antioxidant properties of HDL inhibit LDL oxidation, thereby 
reducing the inflammation and attenuating the uptakes by macrophages.  
As shown in Fig.1 C, LDL must be further modified before it can be taken up by 
macrophages to form foam cells. Minimally oxidized LDL has pro-inflammatory 
properties and stimulates ECs, resulting in the release of adhesion molecules and 
chemotactic proteins. These molecules facilitate leukocytes, e.g. monocytes and T cells, 
to roll on along the endothelial surface and direct them to the lesion sites [18]. LDL can 
be highly oxidized via ROS produced by ECs and macrophages and several enzymes 
such as myeloperoxidase, sphigomyelinase and a secretory phospholipase [9, 19, 20]. 
Macrophages recognize the modified LDL via two major scavenger receptors, SR-A [21] 
and CD 36 [22], and rapidly uptake these particles, leading to foam-cell formation.  
Fibrous plaques are characterized by a growing necrotic core, accumulation of SMCs and 
SMC-derived extracellular matrix (Fig. 1D). The death of foam cells generates a growing 
mass of lipid debris, forming a necrotic core. The interaction between CD40 ligand and 
CD40 expressed on T cells and macrophages contribute to the release of pro-
inflammatory cytokines and growth factors [23]. ECs also express CD40 and the binding 
with its ligand causes the release of adhesion molecules [24]. These mediators recruit 
more leukocytes from circulation into the lesion site and stimulate SMC proliferation. 
Elevated homocysteine levels and hypertension also contribute to the stimulation of SMC 
proliferation [25, 26]. Excess SMCs migrate into intima and secrete extracellular matrix, 
forming a fibrous cap around necrotic core. 
Potential Mechanisms Involved in PM-mediated Atherosclerosis  
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Previous studies have now corroborated the pro-atherosclerotic effects of PM in animals 
such as rabbits and mice [27-29]. Using more physiological relevant whole body 
exposure to concentrated ambient PM, the researchers demonstrated that long-term 
exposure to PM can potentiate plaque development and vascular inflammation in apoE 
deficient mice [28, 30]. Although some important aspects remain elusive, subsequent 
studies have revealed the possible pathways of PM-mediated atherosclerotic lesions, 
which may involve multiple organs, cell types and molecular mediators (Fig.2). PM 
inhalation can provoke an inflammatory response and oxidative stress within lungs with 
mediators (e.g. cytokines, ROS and constituents of PM) “spilling over” into circulation 
[31]. These mediators can cause EC injury and disrupt endothelial barrier integrity, 
thereby enhancing the barrier permeability. An in vitro study demonstrated that PM 
increased ROS level of ECs and disrupted endothelial barrier integrity through p38 
mitogen-activated protein kinase- and heat-shock protein 27-dependent pathways [32]. 
LDL diffuses passively through EC junctions and is oxidized by elevated ROS caused by 
PM or EC injury.  
PM not only promotes the initiation of atherosclerotic lesion via oxidative stress, it also 
accelerates foam-cell formation by modulating inflammatory pathways. Pro-
inflammatory cytokines released from alveolar macrophages, e.g. TNF-α, IL-6 and IFN-γ 
[33, 34], can induce systemic inflammation and activate adipose tissues, secreting pro-
inflammatory adipokines. In addition to contribution to systemic inflammation, some 
adipokines, including adiponectin, resistin, omentin-1 and chemerin, directly modulate 
the atherogenic environment of arterial wall by regulating the function of ECs, SMCs and 
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macrophages [35]. PM can be recognized by intimal macrophages via toll-like receptors 
(TLRs) such as TLR2 and TLR4 [36, 37]. Upon recognition, cytokines and chemotactic 
proteins are released from macrophages possibly through the activation of NF-κB 
pathway [38, 39]. MCP-1 is a key molecule that recruits monocytes from circulation via 
binding to CCR-2 on the cell surface [40]. Recruited monocytes by oxidized LDL and 
PM differentiate into intimal macrophages that uptake the highly oxidize LDL through 
scavenger receptors, forming the foam cells.  
PM inhalation is known to trigger hypertension through abnormal activation of 
sympathetic nervous system [41]. Epidemiological studies have shown elevated blood 
pressure is strongly associated with atherosclerosis [9, 42]. Studies using spontaneously 
hypertensive rats indicate that raised blood pressure stimulates the expression of platelet-
derived growth factor that is a potent mitogen for SMCs [26]. PM-primed macrophages 
also secrete growth factors that may be important for SMC migration and proliferation 
[43]. In addition, macrophages may uptake and remove PM by apoptosis, generating cell 
debris. This debris, together with extracellular lipids from foam cells, facilitates the 
formation of necrotic core. 
Conclusions 
Both in vivo and in vitro studies confirm the pro-atherosclerotic properties of PM 
exposure and reveal the underlying mechanistic pathways. PM-mediated enhancement of 
atherosclerosis is likely due to its pro-oxidant and pro-inflammatory effects, involving 
multiple organs, different cell types, and various molecular mediators. There are many 
issues, however, that have yet to be addressed. The responsible components and the 
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combined effects of other pollutants (e.g. ozone) remain unclear. It is urgent to evaluate 
the toxicity of PM0.1 in human because it may be highly toxic to the cardiovascular 
system. The mechanistic pathways whereby PM exposure mediates dysfunctional HDL 
need to be investigated in details since they may lead to the identification of a therapeutic 
target for atherosclerosis. Future studies on these issues may yield a better understanding 
of PM-mediated atherosclerosis and provide useful information for policy makers to 
determine acceptable levels of PM air pollution. 
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Table 1. Human Studies Linking PM Exposure with Atherosclerosis. 
Authors  Study Design Key Findings Pollutants  Subjects  Year  Location Reference 
Künzli et 
al 
Cross-
sectional study 
Exposure associated with an increase in 
CIMT; with a cross-sectional exposure 
contrast of 10 μg/m3 PM2.5, CIMT increased 
by 5.9%; larger significant effects seen in 
women ≥ 60 years old and subjects taking 
lipid-lowering medications 
PM2.5 798 subjects 
≥ 40 years 
old without 
diabetes or 
CVD 
1998-2003 Los Angeles 
basin, U.S. 
[44] 
Pope et al Case-crossover 
study 
Exposure PM2.5 to strongly associated with 
AIC, with PM2.5 level elevated by 10 μg/m
3
 
PM2.5, AIC increased by 4.5%; 
PM2.5 and 
PM10 
12865 
subjects  
1994-2004 Utah, U.S. [45] 
Hoffmann 
et al 
Cross-
sectional study 
Trends for an increase in CAC of 17.2% per 
3.91 μg/m3 of PM2.5 after controlling for 
other risk factors 
PM2.5 4494 
subjects 45-
74 years old 
2002 Three 
Germany 
cities* 
[46] 
Diez Roux 
et al 
Cross-
sectional study 
CIMT associated with exposures to PM2.5 
and PM10 after controlling for other risk 
factors 
PM2.5 and 
PM10 
5172 
subjects 44-
84 years old 
without 
CVD 
1982-2002 Six U.S. 
regions$ 
[47] 
                                                                                                                                                                                           Continued 
  
1
0
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Table 1 continued. 
Bauer et al Population-
based 
prospective 
cohort study 
PM2.5 exposure associated with CIMT; 
higher effects seen in subjects working full 
time within the past five years 
PM2.5 and 
PM10 
3380 
subjects 45-
75 years old 
2000 Three 
Germany 
cities* 
[48] 
Kӓlsch et 
al 
Cross-
sectional study 
PM2.5 exposure associated with an increase 
in TAC; with a cross-sectional exposure 
contrast of 2.4 μg/m3 PM2.5, TAC increased 
by 18.1% 
PM2.5 and 
PM10 
4814 
subjects 45-
75 years old 
2000-2003 Three 
Germany 
cities* 
[49] 
CIMT: carotid intima-media thickness; PM: particulate matters; CVD: cardiovascular disease; AIC: acute ischemia coronary; 
CAC: coronary artery calcium; TAC: thoracic aortic calcification. * Essen, Mülheim, and Bochum. $ Baltimore, Maryland; 
Chicago, Illinois; Forsyth County, North Carolina; Los Angeles, California; New York, New York; and St. Paul, Minnesota. 
 
 
 
 
 
 
1
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Figure 1. Development of Atherosclerotic Plaque. (A) Normal structure of artery. (B) 
Initiation of atherosclerosis. (C) Foam-cell formation. (D) Fibrous plaque formation. 
LDL: low-density lipoprotein; HDL: high-density lipoprotein; EC: endothelial cell; 
ICAM: intercellular adhesion molecule; VCAM: vascular cell adhesion molecule; 
PCAM: platelet cell adhesion molecule; VLA:  very late antigen; ROS: reactive oxygen 
species; NOS: nitric oxide synthases; CD: cell differentiation; IFN: interferon; TNF: 
tumor necrosis factor; SMC: smooth muscle cell. 
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Figure 2 Mechanistic Pathways of PM-mediated Atherosclerosis. PM: particulate matters; 
LDL: low-density lipoprotein; HDL: high-density lipoprotein; ANS: autonomic nervous 
system; ROS: reactive oxygen species; TNF: tumor necrosis factor; EC: endothelial cell; 
MCP: monocyte chemotactic protein; TLR: toll-like receptor; SMC: smooth muscle cell 
15 
 
Figure 2 
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Chapter 3: Chronic Inflammation in Adipose Tissues 
 
Background  
Obesity is characterized as a chronic state of low-grade inflammation with progressive 
immune cell infiltration into adipose tissue (AT). Obesity and ectopic lipid deposition are 
major risk factors for diseases ranging from insulin resistance (IR) to type 2 diabetes 
mellitus (T2DM) and atherosclerosis. The incidences of these diseases are increased with 
obesity and are thought to arise from the chronic inflammation [44]. It is now accepted 
that AT is the primary source of many pro-inflammatory cytokines. The novel discovery 
that pro-inflammatory macrophages are recruited to obese AT prompted an increased 
interest in the interplay between immune cells and metabolism [45, 46]. 
The findings from animal studies and in vitro experiments have suggested that adipose 
tissue macrophages (ATMs) play critical roles in the establishment of the chronic 
inflammatory state and metabolic dysfunctions such as T2DM and IR [47, 48]. Either 
genetic or diet-induced adipocyte expansion promotes the accumulation of macrophages 
in AT in the mice and the majority of humans [45, 46, 49]. Upon activation, immature 
bone-marrow derived peripheral monocytes migrate into the site of inflammation and 
differentiate into tissue macrophages [50]. Macrophage numbers and/or pro-
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inflammatory gene expression in AT are positively associated with adipocyte size in 
obese mice and are negatively associated with weight loss in obese humans [45, 51].  
Although recruitment of macrophages into AT involves interactions of innate and 
adaptive immunity in multiple organs, at its core lays a unique crosstalk between 
adipocytes and macrophages. In the chapter, we discuss the obesity-mediated adipose 
tissue remodeling, and particularly, the role of adipokines/chemokines in macrophage 
recruitment to obese adipose tissue.  
Adipose Tissue and Adipose Tissue Macrophages 
In addition to the storage of energy in the form of lipids, AT has been recognized as the 
largest endocrine organ secreting several hormones (leptin and resistin) [52], adiponectin 
[53], growth factors (vascular endothelial growth factor) [54], pro- and anti-inflammatory 
mediators (α4 integrin, interleukin (IL)-6, IL-1β and tumor necrosis factor (TNF)-α) [46, 
55], and complement proteins [56, 57]. These factors that are released by AT are 
collectively referred to as adipokines [58]. AT is mainly composed of adipocytes and a 
heterogenous constellation of endothelial cells, adipocyte precursors, nerve terminals, 
fibroblasts, blood vessels, and leukocytes. Each of these cells and structural components 
contribute to the synthesis and turnover of extracellular matrix components that 
collectively create unique microenvironments within AT [59].  
Macrophages and their monocyte precursors are highly heterogeneous cell populations. 
Upon the cytokine polarization, macrophages are divided into classically activated 
macrophages (M1) and alternatively activated macrophages (M2). M1 can be induced by 
interferon-γ alone or in concert with microbial stimuli or cytokines, while M2 can be 
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induced by IL-4, IL-10, IL13, and IL-33 [60]; in general, M1 are characterized by an IL-
12
high
, IL-23
high
, and IL-10
low
 phenotype, in contrast, the various forms of M2 generally 
express an IL-10
high
, IL-12
low
, and IL-23
low 
phenotype [60]. In 2007, Lumeng et al. 
extended this M1/M2 macrophage paradigm into ATMs [61]. Their data indicated that 
ATM phenotype changed from an anti-inflammatory M2 polarized state to a pro-
inflammatory M1 state when obesity occurred, which contributed to the chronic low-
grade inflammation of obesity. 
Obesity-mediated Adipose Tissue Remodeling  
With excessive weight gain, extreme increases in adipocyte size are accompanied by an 
elevated frequency of adipocyte death and macrophage recruitment [62, 63]. Obesity-
associated AT remodeling has been first described by Cinti in 2005 as the existence of 
significant numbers of so-called “crown-like structures (CLS)”, consisting of 
macrophages surrounding dead adipocytes in both obese mice and humans [62] (Fig.3). 
The high prevalence of CLS is highly correlated to AT inflammation and metabolic 
disorder and considered to be pathological lesions in AT of obese subjects [64].  
During AT remodeling, adipocyte death may be sufficient to initiate macrophage 
infiltration and induce AT inflammation [59]. This hypothesis has been further 
substantiated by the study demonstrating that the preponderance of ATMs in lean and 
obese mice and humans is selectively localized to individual dead adipocytes and that the 
frequency of adipocyte death is increased over 30-fold in an obese mouse model as well 
as in obese humans [62]. A nearly complete remodeling of the epididymal fat depot has 
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been observed in a murine diet-induced obesity model, characterized as frequency of 
adipocyte death, an increase of depot weight and ATM accumulation [65].  
Crosstalk between Adipocytes and Macrophages  
The interaction between adipocytes and macrophages aggravates the chronic 
inflammation in obese AT [66]. Pro-inflammatory adipokines such as monocyte 
chemotactic protein [67]-1 and TNF-α, and saturated FAs released by adipocytes interact 
with TLR4 complex, inducing nuclear factor-κB activation in resident macrophages [68, 
69]. Conversely, activated macrophages also release pro-inflammatory chemokines 
including MCP-1, recruiting the monocytes from circulation into the site of AT 
inflammation [70]. Once infiltrated into the AT, monocytes become matured and interact 
with adipocytes in a paracrine manner through TNF-α production, increasing the 
production of pro-inflammatory adipokines and reducing the production of anti-
inflammatory adiponectin [68]. This crosstalk between adipocytes and macrophages 
establishes and maintains the chronic inflammation state in obese AT through persistently 
recruiting new macrophages/monocytes from circulation (Fig.4). 
Adipokines and chemokines are key mediator linking the adipocytes and ATMs and 
regulating AT inflammation. As described above, AT has been recognized as the largest 
endocrine organ secreting a variety of adipokines. Following the onset of obesity, the 
secretory status of adipocytes can be modified by the changes in the cellular composition 
of the tissue, including alterations in the number, phenotype and localization of immune, 
vascular and structural cells. Recent evidence suggests that obesity-induced changes in 
adipokine secretion can influence the AT function through recruiting the immune cells 
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and promoting inflammatory responses [44]. The current section discusses the key 
adipokines and chemokines that have roles in ATM accumulation. 
TNF-α 
TNF-α is a pro-inflammatory cytokine that has been noted as one of active participants in 
the development of obesity-related diseases [71]. TNF-α may contribute to adipokine 
dysregulation in adipocytes and an increased level of TNF-α was found in ATs of obese 
murine models [72]. In humans, TNF-α expression correlated with body mass index, 
percentage of body fat, and hyperinsulinemia, whereas weight loss decreased TNF-α 
level [73]. TNF-α levels were also found to positively associated with other markers of 
IR [74]; while short-term treatment with TNF-α inhibitor in obese patients reduced 
systemic inflammatory markers without improving insulin sensitivity [75]. 
TNF-α converting enzyme (TACE) is the major factor that induces soluble TNF-α and 
has been implicated as a central regulator in obesity and AT inflammation [76]. Previous 
studies have shown that TACE activity is significantly higher in diet-induced obese mice 
compared with control group [77]; and that TACE knock-out mice are protected against 
obesity-induced IR and diabetes [78]. In addition, a recent study showed that serum 
macrophage-related chemokine levels and the number of CLS were significantly elevated 
in ATs of TACE-transgenic mice fed with HFD [79]. These findings collectively 
suggested that TACE could be a possible therapeutic target of obesity-related diseases. 
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Leptin 
Leptin is one of the most important AT-derived hormones, involving in both innate and 
adaptive immunity [80]. Obesity is associated with an increased level of leptin prevailing 
in the expanding AT [81], suggesting the potential role of leptin in obesity-mediated 
inflammation. Leptin-deficient (ob/ob) and leptin receptor-deficient (db/db) mice have 
been well generated and shown less macrophage infiltration and inflammatory gene 
expression in AT, in spite of increased weight gain and adiposity [46]. Furthermore, Dib 
et al. report that C57BLJ mice reconstituted with db/db bone marrow, when placed on a 
high-fat diet, have significant lower body weight and adiposity, attenuated macrophage 
infiltration, and subsequently diminished AT inflammation [82].  
Leptin may affect macrophage infiltration to AT through the upregulation of adhesion 
molecules in the endothelial cells of the stromal vascular compartment [83]. However, 
despite the convincing nature of these findings from the different groups, there are 
equally convincing data showing that leptin does not influence weight gain and 
macrophage infiltration in AT [84, 85]. The contrasting results generated from these 
studies may be caused by different background strain, potential effects of gut microbiota, 
different baseline of body weight, and different percent fat in the diet [86]. Taken 
together, these key elements must be considered to further evaluate the role of leptin in 
the macrophage recruitment in the future studies. 
Adiponectin 
Adiponectin is another novel AT-derived hormone that modulates a number of metabolic 
processes, such as glucose regulation and fatty acid oxidation [87]. Adiponectin is almost 
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exclusively synthesized by adipocytes and is present at high levels (3-30 μg/ml) in the 
blood relative to other adipokines [88]. Previous studies have shown that adiponectin 
may suppress lipid accumulation and have anti-inflammatory effects on macrophages 
[89, 90]; and that adiponetin promotes macrophage polarization to an anti-inflammatory 
phenotype [91]. Ohashi K et al. report that ATMs isolated from adiponectin knock-out 
mice displayed increased M1 markers and decreased M2 markers; while in vitro, the 
treatment of macrophages with recombinant adiponectin led to an increase in the levels of 
M2 markers [91]. Thus, adiponectin-mediated modulation of macrophage function and 
phenotype may contribute to its role in reducing inflammation within AT. 
Fatty Acids 
AT regularly releases FAs through the process known as lipolysis, in which involves the 
breakdown of lipids and hydrolysis of triglycerides into glycerol and free FAs. 
Macrophages express a variety of free FA receptors including TLRs, CD36, and GPCRs 
[92-94]. TLR4 binds to  free FAs such as palmitate and stearate indirectly via an 
endogenous ligand like Fetuin-A [95], causing the activation of nuclear factor-κB and 
subsequent formation of pro-inflammatory cytokines and prostaglandins via increased 
expression of cyclooxygenase-2 [69, 96]. CD36, the class B scavenger receptor, 
facilitates uptake of long chain FAs and contributes to inflammatory responses by 
promoting macrophage infiltration into AT and expression of pro-inflammatory cytokines 
[97]. CD36 knockout mice show improved insulin sensitivity and reduced inflammation 
within AT [98]. GPCR120 selectively binds omega-3 FAs and leads to blockage of 
nuclear factor-κB resulting in reduced inflammatory responses [94].  
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In vitro, saturated FAs such as palmitate induce extracellular release of histone H3 in part 
through reactive oxygen species and c-Jun N-terminal kinases signaling. Extracellular H3 
activates endothelial cells to express adhesion molecules such as ICAM-1 and VCAM-1 
that recognize and interact with integrins, thereby facilitaing the firm adhesion of 
leukocytes to endothelial cells and contributing to leukocyte trafficking [99].  
MCP-1 
To date, MCP-1-CCR2 system is the most well studied chemokine-chemokine receptor 
system in ATM recruitment. Human study indicates that although obesity is associated 
with the increased expression of several chemokine genes in AT, only MCP-1 is secreted 
into the extracellular space, where it influences the function of adipocytes and acts as 
recruitment factor of macrophages [100]. MCP1 directs recruitment of pro-inflammatory 
macrophages to sites of inflammation [101]. In addition to blood monocyte recruitment, 
local proliferation of macrophages (only in visceral adipose tissue) driven by MCP-1 
contributes to obesity-associated adipose tissue inflammation [102]. CCR2 plays a role in 
the maintenance of ATMs and IR once obesity is established [103]. Both in vivo and in 
vitro evidence supports that CCR2 in BM cells plays a role in the recruitment of 
macrophages into obese AT [104]. CCR2 antagonist (CCX417) can reduce inflammation 
in AT in models of T2DM [105]. 
However, controversy exists regarding the exact role of this system. In contrast to these 
findings, Inouye et al. report that MCP-1 may not be crucial for AT macrophage 
recruitment [106]. In that study, they used male 6-week-old MCP-1 deficient mice to 
evaluate the macrophage infiltration after 28 weeks of HFD feeding. Surprisingly, MCP-
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1 deficient mice on HFD showed alterations of metabolic function, but no reductions in 
ATMs compared with wild-type mice, indicating that MCP-1 has effects on metabolism 
that are independent of its macrophage-recruiting capabilities [106]. Their results were 
confirmed by another group in the following year [107]. Taken together, all reported 
studies show that over-expression of MCP-1 in AT elevates macrophage recruitment [70, 
108], and that CCR2 deficiency or inhibition reduces macrophage recruitment [103-105, 
109, 110]. However, whether deficiency of MCP-1 can reduce macrophage recruitment 
and improve insulin sensitivity remains conflicting [106, 107, 111]. The complexity and 
redundancy of chemokine signaling may account for these conflicting results. In fact, 
CCR2 is a functional receptor shared by several other chemokines including MCP-2, 
MCP-3, CCL7 and CCL8, which are all expressed in obese AT and may affect 
macrophage recruitment [112, 113].  
Conclusion 
Significant progress has been conducted to identify the molecules that regulate ATM 
recruitment and the roles of these molecules in obesity-related diseases. Adipokines have 
both pro-inflammatory and anti-inflammatory effects and the balance between these 
effects in normal state of nutrition determines the local and systemic inflammatory status. 
Imbalanced adipokine production during over-nutrition contributes to AT inflammation 
and obesity-related diseases such as IR and atherosclerosis. Chemokines have roles in 
recruitment of monocytes from circulation and in situ proliferation of ATMs. There are 
many questions, however, that have yet to be addressed particularly due to the 
complexity and redundancy of chemokine signaling. Thus, further investigation of the 
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functions and mechanisms of key adipokines/chemokines will lead to a better 
understanding of the pathogenesis of obesity and related disorders. Moreover, therapeutic 
strategies that counteract the dysregulation of adipokine production could be a potential 
and promising means for treating obesity-related diseases, e.g. IR and atherosclerosis. 
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Figure 3. Obesity-mediated Adipose Tissue Remodeling. AT: adipose tissue. ATM: 
adipose tissue macrophages. 
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Figure 4. Chronic Inflammation in Obese Adipose Tissue. TLR: toll-like receptor; CD36: 
cluster of differentiation 36; MCP-1: monocyte chemotactic protein-1; CCR2: C-C 
chemokine receptor type 2; NF-κB: nuclear factor-κB. 
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Chapter 4: Potential Impacts of Strawberries on Cardiovascular Diseases 
 
Background 
Strawberries are a rich source of polyphenols, ellgtigannins, vitamin C, folic acids, 
postassium, and fiber. Approximately 40 phenolic compounds, including vitamin C, 
ellagitannins and anthocyanins, have been identified in strawberries. The antioxidant 
activity of these compounds has been well documented and accounts for the benefits of 
strawberries. Flavonoids are potent antioxidants as they are effective scavengers of 
hydroxyl and peroxyl radicals. In vitro studies indicate that many flavonoids are more 
evident antioxidants than vitamin C and E [114]. Phenolic acids are also promising 
antioxidants and work synergistically with other antioxidants. The most prevalent 
phenolic acids in strawberries include ellagic acid, tannic acid, and capsaicin [115]. The 
cellular antioxidant activity assay revealed that apples and strawberries are the largest 
contributors to dietary antioxidant activity [116] 
Strawberries are now considered a functional food with multiple health benefits, e.g. 
lowering lipids, anti-oxidation, and anti-inflammatory responses. It has been shown that 
fresh strawberries can attenuate postprandial hyperglycemia in health subjects when 
compared to those receiving a matched glucose [117]. A similar study conducted among 
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hyperlipidemic adults showed that freeze-dried strawberry supplementation can 
significantly attenuate postprandial lipemia and lipid oxidation in response to a high-fat 
diet challenge [118]. The prevailing evidence indicates that strawberries may have 
promising implications in the management of metabolic syndrome and cardiovascular 
disease (CVD). Thus, the main objective of this chapter is to discuss the nutrients of 
strawberry related to human health and summarize the key findings from both 
epidemiological and experimental studies.  
Strawberry Nutrients and Phenolic Compounds 
Strawberries are a rich source of several nutrients, phytochemicals and fiber (Table 2); 
these elements, particularly phytochemicals, contribute to their biological effects. 
Strawberries contain significant amounts of vitamins, potassium, folic acid, carotenoids, 
and specific flavonoids, e.g. pelargonidin, quercetin, and catechin. Strawberries also have 
significant amounts of ellagic acid, tannins, and phytosterols [119]. Phenolic compounds 
are the best-studied phytochemicals in strawberries and are very bioactive in animals and 
humans who consume them. These compounds are composed of one or more aromatic 
rings between one or more hydroxyl groups. There are hundreds of different phenolic 
compounds in plant, but flavonoids and phenolic acids are the most common phenolic 
compounds found in strawberries. This section discusses these compounds and their 
bioactivities.  
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Flavonoids 
The main flavonoids found in strawberries are anthocyanin, catechin, quercetin, and 
kaempferol. These compounds share similar chemical structure and are present in plants 
as aglycones or flavonoid glycosides. Anthocyanin is a large subclass of flavonoid plant 
pigments and its structures depend on environmental pH. In strawberries, anthocyanins 
are the most abundant flavonoids. Catechin is a monomeric flavanol compound present in 
strawberries as part of a complex mixture of phenolic substances. Quercetin and 
kaempferol belong to the subclass of flavonoids known as flavonols, which represent 
about 11% of the phenolic compounds in strawberries [120]. It has been suggested that 
all of these flavonoids are potent antioxidants and have protective effects on CVDs and 
cancer [114]. 
Both in vivo and in vitro studies have shown that cyanidin, an isoform of anthocyanins, 
acts as a potent scavenger against hydroxyl radicals and superoxide [121, 122]. In a 
mouse model of skin cancer, high dose of anthocyanin extracts can reduce the promotion 
of tumors via inhibition of protein kinase C [123]. Catechin has also been claimed as a 
potential anticancer compound. In a spontaneous tumor model, HTLV-1 tax transgenic 
mice, dietary catechin (4 mmol/kg) can postpone the onset of tumor development by 45% 
[124]. Quercetin and kaempferol have been shown to block the activation of certain 
carcinogens via inhibition of DNA adducts formation [125]. In rats treated with several 
carcinogens, quercetin at 1% of the diet can significantly inhibit adenomas and 
carcinomas in small intestines instead of other organs [126].  
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Ellagic Acid 
Ellagic acid is widely distributed phenolic acids in food, e.g. berries, grapes and walnuts. 
It presents both in the free form and esterified to glucose in water soluble hydrolysable 
ellagitannins. It has been reported that ellagic acid comprises 51% of the phenolic acids 
in strawberries [127]. In comparison to other fruits such as raspberries, pinapples, and 
pomegranates, strawberries appear to contain higher ellagic acid.  
The antioxidant properties of ellagic acid have been reported in numerous in vitro and 
animal studies [128, 129]. Its four hydroxyl and two lactone functional groups act as 
hydrogen bond acceptors and donors, respectively. This enables ellagic acid to work as a 
potent scavenger against a variety of ROS [130]. In addition, ellagic acid exerts indirect 
effects against oxidative stress via upregulation of Nrf2, which is a redox-sensitive 
transcription factor regulating the antioxidant response in the cell [130]. Furthermore, 
ellagic acid can increase glutathione (GSH) levels through upregulation of GSH 
synthetase [131]. These biological effects of ellagic acid collectively attribute to its 
antioxidant properties. 
Previous studies have also claimed that ellagic acid has anti-proliferative properties and 
may prevent cancer in animals and humans. The treatment of ellagic acid can 
significantly reduce the incidence of lung tumors in newborn mice receiving carcinogen 
injection [132]. In rats, ellagic acid supplementation inhibits the development of 
esophageal cancer induced by N-nitrosomethylbenzylamine by 25-50% [133]. An in vitro 
study using human breast cancer cell line MCF-7 showed that 30 μM of ellagic acid 
inhibited carcinogenesis by 45% [134]. Anticancer effects of ellagic acid may be due to 
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multiple mechanisms. First, ellagic acid can inhibit the activation of microsomal 
cytochrome P450 enzymes, which are primary enzymes known to activate certain 
carcinogens, e.g. nitrosamine, aniline and benzene [135]. Second, ellagic acid may induce 
hepatic phase II detoxifying enzymes including glutathione S-transferase, NADPH, and 
UDP glucuronosyl-transferse [114]. At last, ellagic acid may inhibit cancer initiation by 
removing oxygen free radicals and the reactive metabolites of carcinogens [114]. 
Strawberries and CVDs 
As previously discussed, oxidation of LDL is the key step in the development of 
atherosclerosis. The antioxidant properties of phenolic compounds have been elucidated 
as primary reasons for the health benefit of strawberries. These compounds may reduce 
the oxidation of LDL and thus prevent the progression of atherosclerosis.  
Epidemiological Studies 
Previous epidemiological studies have shown that consumption of fruits and vegetables 
rich in flavonoids is associated with lower risk for CVDs [136, 137]. The data collected 
from the INTER-HEART study, investigating three dietary patterns from 52 countries, 
indicate that the consumption of fruits and vegetables is inversely associated with the risk 
for myocardial infarction [138]. The researchers concluded that an unhealthy dietary 
intake increased the risk of myocardial infarction globally and accounted for approximate 
30% of the population-attributable risk.  
The findings of a large population study reveal that flavonoid intake, e.g. anthocyanins, 
may contribute to the prevention of hypertension [139]. In this study, 46,672 women 
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from the Nurses’ Health Study I, 87,242 women from the NHS II, and 23,043 men from 
the Health Professionals Follow-Up Study were followed up for 14 years to monitor the 
hypertension and flavonoid intakes. The pooled multivariate-adjusted analyses found that 
subjects with the highest anthocyanin intake had an 8% reduction in risk for hypertension 
compared to those with the lowest intake [139]. Another prospective study including 
34,489 postmenopausal women in the Iowa Women’s Health Study showed that 
significant inverse associations were observed between anthocyanin intake and CVD, 
coronary heart disease (CHD) and total mortality [RR (95% CI)] after multivariate 
adjustment [140]. These observational data suggest that consumption of fruits rich in 
flavonoids may contribute to the reduction of the risk for CVD.  
Clinical Studies 
Human intervention studies, using fresh, frozen, or freeze-dried strawberries, have shown 
the therapeutic potentials of strawberries in counteracting oxidative challenges caused by 
high-fat diet, hyperlipidemia or metabolic syndromes. In 27 subjects with metabolic 
syndrome, freeze-dried strawberries (4 cups a day for 8 weeks) can significantly reduce 
the levels of total cholesterol, LDL, and circulating adhesion molecules, e.g. VCAM-1 
[141]. A similar study, conducted by the same group, showed that even short-term 
strawberry supplementation (2 cups a day for 4 weeks) decreased the levels of total 
cholesterol and LDL by 5% and 6%, respectively (p < 0.05) [142]. The researchers found 
that plasma ellagic acid was elevated after four-week strawberries treatment [142], 
indicating that this compound may claim the effects on lowering the risk factors for 
CVDs.  
34 
 
Postprandial hyperglycemia and hyperlipidemia can cause endothelial dysfunction and 
contribute to the development of atherosclerosis [143]. The effects of strawberries on 
postprandial hyperglycemia, hyperlipidemia, oxidative stress and inflammatory responses 
have been studied in clinical trials with a high-fat or high-glucose challenge. In obese 
subjects (BMI: 29.2 ± 2.3 kg/m
2
), six-week strawberry intervention significantly lowered 
postprandial platelet activation factor (PAF)-1 and IL-1β [144]. In healthy subjects or the 
patients with hyperlipidemia, strawberries were suggested to increase postprandial 
plasma antioxidant ability [145], reduce the postprandial glucose response [146], and 
attenuate postprandial hyperlipidemia or lipid oxidation [118], after a high-fat diet 
challenge. The postprandial benefits of strawberries on lipid profile, oxidation and 
inflammation suggest their protective potentials in CVDs. 
Experimental Studies 
Mechanistic studies in animal and cell culture models provide compelling evidence on 
the roles of strawberry fruits, extracts, or purified anthocyanins in the ameliorating 
inflammation, oxidative stress, hypertension, and hyperlipidemia, which are the risk 
factors for CVDs. It has been shown that quercetin and kaempferol reduce the release of 
mast cells from guinea pigs and rats, respectively [147, 148]. Emerging evidence has 
suggested the contribution of mast cells to CVDs, in particular, by the effects on 
atherosclerotic plaque progression and destabilization [149]. In mouse primary peritoneal 
macrophages treated with lipopolysaccharide (LPS), strawberry treatment for 48 hours 
significantly reduced pro-inflammatory cytokines, e.g. IL-1β and IL-6, while markedly 
increased the levels of IL-10 [150]. The anti-inflammatory properties of strawberries are 
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also found in preclinical mouse model, showing the decreased levels of TNF-α, IL-1β and 
IL-6 after strawberry intervention [151]. Since the roles of inflammation in 
atherosclerosis have been well documented, these anti-inflammatory effects of 
strawberries may help reduce the risks for CVDs. 
Antioxidants are crucial in the prevention of CVDs since they can inhibit LDL oxidation. 
Antioxidants may promote plaque stability, improve vascular endothelial functions and 
reduce tendency of thrombosis. An in vitro study found that most of phenolic 
compounds, e.g. catechin, quercetin, cyaniding and caffeic acid, have antioxidant effects 
[152], although no synergistic effects were seen among these compounds. Strawberry 
extracts such as gallic acid equivalents and acetone were shown to inhibit oxidation of 
human LDL and hydroperoxide formation in a dose-dependent manner [153]. Ellagic 
aicd treatment was also shown to inhibit oxidized LDL-induced proliferation of rat aortic 
smooth muscle cells [154]. These antioxidants from strawberries prevent CVDs through 
inhibition of LDL oxidation, the key step for initiation and development of 
atherosclerosis. 
A recent study using in vitro models reported that phytochemicals from strawberries 
inhibited the activities of α-glucosidase, α-amylase and angiotensin I converting enzyme 
(ACE) [155]. The inhibitory effects on these enzymes are relevant for the management of 
hyperglycemia and hypertension. Further details were released from a cultivar-specific 
study: among all strawberry cultivars, Ovation exhibited the greatest α-glucosidase 
inhibitory activity; Honeoye, Idea, and Jewel exhibited moderate α-amylase inhibition; 
Jewel and Ovation showed moderate ACE inhibition [156]. In addition, it has been 
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reported that these polyphenols from strawberries inhibit the protease and lipase 
activities, suggesting a novel therapeutic potential of this fruit as macronutrient enzyme 
inhibitors in obesity, dyslipidemia and hyperglycemia [157, 158].   
Conclusion 
As one of the most popular fruits in the United States, strawberries rich in 
phytochemicals (e.g. flavonoids and ellagic acid), micronutrients (e.g. vitamins and 
carotenoids) and fibers are termed as a functional food. Studies on the individual 
compounds have demonstrated anticancer, antioxidant, and anti-inflammatory activities. 
Because of these properties of the phenolic compounds, consumption of strawberries may 
help reduce the risk for cancer and heart diseases. Indeed, inhibitory effects of 
strawberries on LDL oxidation and inflammation have been well understood on a basis of 
animal and in vitro studies. These findings need further investigation in larger clinical 
trials. Future studies are needed in defining the optimal dose, form and duration of 
strawberry intervention in the management of CVDs. Such studies will provide evidence 
in the mechanistic pathways of strawberry-mediated protective effects on heart disease. 
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Table 2. Nutritional Content of Strawberries. 
Value/100 g Strawberries, raw Strawberries, frozen, 
unsweetened 
Strawberries, frozen, sweetened, 
whole 
Strawberries, frozen, 
sweetened, sliced 
Water (g) 90.95 89.97 78.05 73.18 
Energy (kcal) 32 35 78 96 
Protein (g) 0.67 0.43 0.52 0.53 
     
Carbohydrate (g) 7.68 9.13 21 25.92 
Fiber (g) 2.0 2.1 1.9 1.9 
Calcium (mg) 16 16 11 11 
Iron  (mg) 0.41 0.75 0.47 0.59 
Magnesium  (mg) 13 11 6 7 
Phosphorus  (mg) 24 13 12 13 
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Table 2 continued.      
Potassium  (mg) 153 148 98 98 
Sodium  (mg)  1 2 1 3 
Zinc (mg) 0.14 0.13 0.05 0.06 
Vitamin C  (mg) 58.8 41.2 39.5 41.4 
Thiamin  (mg) 0.024 0.022 0.015 0.016 
Riboflavin  (mg) 0.022 0.037 0.077 0.051 
Niacin  (mg) 0.386 0.462 0.293 0.401 
Vitamin B-6  (μg) 0.047 0.028 0.028 0.03 
Vitamin A, IU 12 45 27 24 
Fatty acids, total 
saturated (g) 
0.015 0.006 0.007 0.007 
Fatty acids, total 
polyunsaturated (g) 
0.155 0.054 0.068 0.064 
Source: National Nutrient Database for Standard Reference Release 27, United States Department of Agriculture.
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Chapter 5: The Characteristics of PM2.5 Air Pollution Collected via Ohio Air Pollution 
Exposure System for Interrogation of Systemic Effects 
 
Abstract 
Previous evidence has provided a link between fine particulate matter (PM2.5) air 
pollution and human health. To explore the local level of PM2.5 and its characteristics, 
PM2.5 was collected using “Ohio Air Pollution Exposure Systems for Interrogation of 
Systemic Effects” at Columbus, Ohio. Mass concentration and major elements were 
determined by gravimetric analysis and high-resolution inductively coupled plasma-mass 
spectrometry, respectively. In addition, black carbon was collected using Aethalometer; 
correlation between the two pollutants was calculated. Our data showed that PM2.5 level 
in our sampling site was below Environmental Protection Agency standards, and peaked 
on Jul-Aug and Nov-Dec; chemical composition of PM2.5 was dominated by sulfates. Our 
data also revealed that black carbon and PM2.5 were modest related, indicating that black 
carbon could serve as another marker for air pollution. 
Background 
Fine particulate matter (PM2.5) air pollution has undoubtedly raised a global concern to 
the governments and public. Although epidemiological studies have provided compelling 
evidence linking PM2.5 and human health effects [159-161], in vivo animal studies are 
indispensable to elucidate the underlying molecular and cellular mechanisms. One of 
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major challenges in animal studies is how to deliver PM2.5 to experimental subjects. 
Intranasal instillation is a feasible method and has been used in recent particle exposure 
studies [162-164]. However, this method has significant flaws. First, it requires 
anesthesia to successfully deliver PM2.5, which may change the animal physiology and 
affect the outcomes. Second, most of air pollution exposure in “real world” is chronic 
process; the concentration and composition of PM2.5 are usually dynamic during the 
exposure. Intranasal instillation may not mimic this process. Finally, this method requests 
well-trained lab technicians to perform consistently, which may not be suitable for large 
number of animal exposure. 
Our PM2.5 sampling and exposure system, the “Ohio Air Pollution Exposure System for 
Interrogation of Systemic Effects (OASIS)”, is a versatile aerosol concentration and 
enrichment system. This system was designed and constructed by Chen Lab at New York 
University to perform air pollution health effect studies [165]. This system consists of 
two PM2.5 concentrator and four reinforced stainless steel Hinner-type whole-body 
inhalation chambers. The PM2.5 concentrators are three-stage aerosol concentrator that 
utilizes the technology of virtual impactors to concentrate ambient PM2.5. Whole-body 
inhalation chambers are used to hold mice and the maximum capacity of each are 32 
mice. Two chambers are exposed to concentrated ambient particles (CAPs), while the 
others are exposed to filtered air (FA) as control with the same air flow rate. This system 
allows us to collect local PM2.5 samples and perform systemic analysis of PM2.5-
associated physiology and pathology in mouse models. 
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The current study was designed to determine the local PM2.5 level and its characteristics, 
and to explore another potential marker for air pollution. In addition, we aimed to 
compare the composition distribution of CAPs with that of ambient air (AA). 
Material and Methods 
PM2.5 Sampling Sites 
PM2.5 samples were collected via “OASIS” that was located in 2001 Polaris Parkway, 
Columbus, OH 43240. Fig.5 is a map of Columbus showing the location of our sampling 
site as well as three Environmental Protection Agency (EPA) sampling sites (site 1: 5750 
Maple Canyon, Columbus, OH 43229; site 2: State Fairgrounds, Columbus, OH 43211; 
site 3: 1700 Ann Street, Columbus, OH 43207). Our study site experiences heavy motor 
vehicle traffic due to its proximity to interstate 71 (I-71) and the entrance to Polaris 
Fashion Place. 
PM2.5 Sampling Protocol 
PM2.5 was collected using “OASIS”, 6 hour a day, 5 days a week for 12 months. The 
particles in FA, AA and CAPs were deposited on Teflon filters (37 mm, 0.2 μm pore, Pall 
Corporation, Ann Arbor, MI) for gravimetric and trace element analyses. 
Gravimetric Analysis 
Gravimetric analysis was conducted using a microbalance (MT-5 Mettler Toledo, 
Columbus, OH) in a temperature/humidity-controlled room as described in Federal 
Reference Method (Core of Federal Regulations, EPA 1999b). PM2.5 mass concentration 
was calculated using equation: mass concentration (μg/m3) = [net weight (mg) x 1000] ÷ 
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[air flow (liter per minute) x exposure time (minute) ÷ 1000]. After gravimetric analysis, 
the filters were delivered to University of Michigan for trace element analysis. 
Trace Element Analysis 
Teflon filters were placed in 15 mL centrifuge tubes and were wetted with 150 μl of 
ethanol before extraction in 10 mL of 10% HNO3. The extraction solution was sonicated 
for 48 hours and then given two-week acid-digest. The extracts were analyzed for trace 
elements using high-resolution inductively coupled plasma-mass spectrometry 
(Element2, Thermo Finnigan, San Jose, CA). 
Black Carbon Measurement 
Ambient black carbon was monitored by Aethalometer (Anderson Instruments 
Incorporated) between Jan 2012 and May 2013. Air sample was collected as a spot on a 
roll of filter tape. When the density of the spot reached a pre-set limit, the tape advanced 
to a new spot and the collection continued. The average concentration of absorbing black 
carbon was calculated based on the measurement of sample flow rate and the 
instrument’s optical and mechanical characteristics.   
Data Analyses 
Pearson product-moment correlation coefficient between ambient PM2.5 and black carbon 
was calculated using EXCEL. PM2.5 concentrations were presented as mean ± S.D., and 
were analyzed by unpaired student t-test (two-sided) using Prism 4.0 (GraphPad 
Software, Inc, San Diego, CA).  
Results 
Ambient PM2.5 Level in Our Study Site 
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The overall trend of ambient PM2.5 collected by our system was consistent with that 
reported by EPA (Fig.6A). An average of ambient PM2.5 concentration in our study site 
was 9.5 (μg/m3), ranging between 2.1 and 18.5 (μg/m3); while that reported by EPA was 
10.2 (μg/m3), ranging between 2.0 and 16.7 (μg/m3). Our data indicate that ambient PM2.5 
levels in Columbus area are below either EPA 24-hour PM2.5 standard (35 μg/m
3
) or 
annual PM2.5 standard (15 μg/m
3
) (Revised by EPA on Sep 21, 2006). 
In our study site, ambient PM2.5 concentration in the first half year was slightly lower 
than that in the second half year (Fig.6A). Ambient PM2.5 levels peaked on Jul-Aug and 
Nov-Dec during exposure time, which was coincident with the traffic peak during 
summer and winter holidays. This indicates that motor vehicle emission may be the 
primary source of ambient PM2.5 at our study site. Indeed, our sampling site is located 
near the I-71 (< 0.5 mile) and the entrance to Polaris Fashion Place (< 1 mile), 
experiencing the heavy traffic particularly during the holiday seasons.  
Ambient Black Carbon Level in Our Study Site 
In addition to monitoring ambient PM2.5 level, we also detected black carbon in AA using 
Aethalometer. As shown in Fig.6B, the relative higher level of black carbon clustered in 
the second half year, with a peak on Oct during the sampling period. To explore the linear 
correlation between ambient PM2.5 and black carbon, we calculated Pearson product-
moment correlation coefficient. Our result showed that ambient PM2.5 and black carbon 
were positively related (R
2
 = 0.3) (Fig.7), indicating a modest linear relationship between 
two air pollutants.  
Characteristics of CAPs 
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During the sampling periods, the average mass concentrations of AA and CAPs were 9.5 
μg/m3 and 86.3 μg/m3, respectively. PM2.5 mass concentration in CAPs was significantly 
higher than that in FA (Fig.8A). The major chemical composition in our study site was 
dominated by sulfates; other significant elements included calcium, sodium and iron in 
AA and CAPs (Fig.8B). Our data showed that PM2.5 composition distributions of AA and 
CAPs were identical, indicating that “OASIS” only concentrated AA without changing 
the chemical composition. Table 3 shows the details on elemental mass concentrations of 
FA, AA and CAPs in 2012. As expected, elemental levels in FA were quite low and can 
be ignored compared with those in CAPs. 
Discussion 
In the present study, we identified the seasonal trend of ambient PM2.5 and explored the 
association between ambient PM2.5 and black carbon at Columbus, Ohio. In addition, we 
characterized the compositions of CAPs collected by our exposure system, providing the 
details on the chemical species that may contribute to the adverse effects of ambient 
PM2.5 on experimental animals.  
The overall trend of ambient PM2.5 collected by our system was consistent with the 
average reported by three EPA sites, although the level of PM2.5 collected in our study 
site appeared to be slightly lower than those reported by EPA. This indicates that our 
exposure system “OASIS” is feasible for monitoring the local PM2.5 and is, therefore, 
suitable for systemic studies in the physiological effects of PM2.5 on animal models. 
Indeed, this system has been extensively used by several laboratories investigating the 
adverse effects of PM2.5 on murine models, e.g. spontaneously hypertensive rats, diet-
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induce obese mice and atherosclerotic mice [166-168]. This system has a great capacity 
to expose up to 128 mice, allowing us to study multiple projects or treatments 
simultaneously. 
Our data, combined with the data released by EPA, showed that ambient PM2.5 levels in 
Columbus area were below EPA standard. In our study site, ambient PM2.5 concentration 
in the first half year was slightly lower than that in the second half year; ambient PM2.5 
levels tended to peak on Jul-Aug and Nov-Dec during sampling time. This indicates that 
motor vehicle emission may be the primary source of ambient PM2.5 at our study site. As 
shown in the map, our sampling site is located near the I-71 (< 0.5 mile) and the entrance 
to Polaris Fashion Place (< 1 mile). Heavy traffic during school opening and holidays 
may contribute to the increases in ambient PM2.5 levels. Modified land use regression 
models have provided a clear link between traffic and PM air pollution [169]. Future 
study, focusing on the association of traffic pattern with ambient PM2.5 at our study site, 
will be critical to monitor and control this pollutant.  
Our result showed that ambient PM2.5 and black carbon were positively related (R
2
 = 0.3), 
indicating a modest linear relationship between two air pollutants. Black carbon is the 
sooty part of PM, emitted by incomplete combustion of biofuel, fossil fuel and biomass 
[170]. In contrast to PM2.5 and other particulates, black carbon absorbs sunlight 
efficiently. This absorption clearly leads to local heating of the atmosphere and global 
climate change [171, 172]. Furthermore, black carbon may trigger airway inflammation 
and lung cancer, particularly in children and occupational exposure workers [173, 174]. 
As the effects of black carbon have become understood in recent year, it is urgent that 
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this pollutant is monitored more comprehensively and treated as an important target of 
environmental control, which is currently patchy. 
It has become evident that PM2.5 is associated with airway inflammation, cardiovascular 
diseases, and metabolic disorders [31, 175, 176]. In addition to PM2.5 mass, different 
chemical compositions of this pollutant contribute to divergent health effects. A study 
conducted in Detroit and Grand Rapids revealed that despite similar mass concentrations 
in CAPs at both sites, exposed animals exhibited divergent airway allergic responses 
which may be dependent on some specific chemical characteristics of PM2.5 [177]. 
However, chemical-specific effects of PM2.5 are poorly understood. The major chemical 
composition in our study site was dominated by sulfates, followed by other significant 
elements including calcium, sodium and iron. Previous in vitro studies claim that 
transition metals, particularly iron, are major factors mediating oxidative stress in 
response to PM exposure [178].  
Our data showed that PM2.5 composition distributions of AA and CAPs were identical, 
indicating that “OASIS” only concentrated AA without changing the chemical 
composition. As previously discussed, chemical compositions also play crucial roles in 
PM2.5-mediated health effects. This property of our exposure system allows us to mimic 
the effects of PM2.5 air pollution in “the real world”. 
Taken together, the studies described here enable us to reveal the annual level and 
seasonal trend of PM2.5 in Columbus, Ohio. Black carbon could be used as another 
marker to monitor local air pollution. Future studies of tracking emission sources and 
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determining chemical-specific toxicological responses will help clarify the relationship 
between the compositions of PM2.5 and human health effects. 
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Figure 5. Map of Our Study Site. Bottom: the map showing our study site as well as EPA 
sampling sites. Top: the enlarged map showing the distances from our study site to 
highway (I-71) or shopping mall (Polaris Fashion Place). The distance was measured by 
google map. EPA: Environmental Protection Agency. 
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Figure 6. Ambient PM2.5 and Black Carbon. (A) The concentrations of ambient PM2.5 
collected from our study site (OASIS) and by EPA (averaged values) in 2012. (B) 
Ambient black carbon monitored in our study site from Jan, 2012 to May, 2013. PM2.5: 
fine particulate matters; OASIS: “Ohio Air Pollution Exposure Systems for Interrogation 
of Systemic Effects”; EPA: Environmental Protection Agency. 
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Figure 7. Correlation between Ambient PM2.5 and Black Carbon. Pearson product-
moment correlation coefficient was calculated using EXCEL. 
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Figure 8. Characteristics of PM2.5 Collected via OASIS. (A) Mass concentrations of FA, 
AA and CAPs. (B) Major composition distributions of FA, AA and CAPs. PM2.5: fine 
particulate matters; OASIS: “Ohio Air Pollution Exposure Systems for Interrogation of 
Systemic Effects”; FA: filtered air; AA: ambient air; CAPs: concentrated air particles. * p 
< 0.05 vs. FA group. 
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Table 3. Trace Elements of PM2.5 Collected via OASIS in 2012. 
Trace Element 
(ng/m
3
) 
OASIS  
FA AA CAPs 
S32 39.8 810.4 7335.8 
Ca44 79.0 80.9 686.6 
Na23 33.8 55.1 422.5 
Fe57 10.1 45.1 442.7 
K39 25.4 45.0 342.5 
Al27 20.3 23.1 187.4 
Mg24 8.0 17.6 183.6 
Zn66 5.4 11.9 92.3 
P31 3.6 8.4 60.7 
Cr52 7.0 3.3 14.1 
Ba137 0.6 3.0 28.5 
Pb208 2.5 3.0 22.4 
Cu63 1.7 2.8 24.9 
Mn55 0.2 1.9 18.4 
Ti47 0.1 0.9 9.0 
Se77 0.0 0.8 7.9 
Sb123 0.1 0.7 6.2 
As75 0.0 0.6 5.1 
Ni60 0.4 0.5 2.4 
Sr88 0.1 0.5 4.2 
Mo95 0.2 0.3 2.8 
Cd111 0.5 0.3 1.7 
V51 0.0 0.2 2.0 
Co59 0.1 0.2 0.7 
Rb85 0.0 0.1 0.6 
Ce140 0.0 0.0 0.4 
La139 0.0 0.0 0.3 
PM2.5: fine particulate matters; OASIS: “Ohio Air Pollution Exposure Systems for 
Interrogation of Systemic Effects”; FA: filtered air; AA: ambient air; CAPs: concentrated 
air particles. 
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Chapter 6: Long-term PM2.5 Air Pollution Exposure Potentiated Atherosclerosis and 
Inflammation in a Mouse Model 
 
Abstract 
Both epidemiological and empirical data have demonstrated the association between 
long-term exposure to fine particulate matters (PM2.5) and the burden of atherosclerosis. 
This study was designed to explore the underlying mechanisms and identify potential 
targets for prevention of atherosclerosis. ApoE
-/-
 mice, a spontaneous atherosclerotic 
model, were exposed to filtered air or concentrated ambient particles using “Ohio Air 
Pollution Exposure Systems for Interrogation of Systemic Effects” for 6 months. After 
PM2.5 exposure, plaque area and lipid area of aorta were evaluated using hematoxylin – 
eosin staining and oil-red O staining, respectively. In addition, total cholesterol, high-
density lipoprotein and fasting glucose were quantitated using diagnostic kits. 
Furthermore, the levels of plasma cytokines were determined via ELISA kits and the 
mRNA levels of cytokines in the lung tissues were measured using real-time PCR. Our 
data showed that long-term PM2.5 exposure potentiated atherosclerosis and modified the 
lipid profile in circulation; that interleukin-6 was the key inflammatory cytokine that may 
play a role in this process. These findings lead us to explore the protective effects of anti-
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inflammation using natural nutrients such as strawberry on the development of 
atherosclerosis after long-term PM2.5 exposure. 
Background 
Atherosclerosis is a specific form of arteriosclerosis in which an artery wall thickens and 
eventually reduces elasticity due to a chronic vascular inflammation. Cholesterol and 
inflammation are major components of atherosclerosis and considered to act as partners 
in all developmental stages of the disease [179, 180]. Lipoproteins retained by matrix 
proteoglycans in the intimal layers of the arterial wall are susceptible to undergo 
oxidative modifications, and this event is followed and potentiated by an immediate 
innate immune response [181, 182]. This process is promoted by low-density lipoprotein 
(LDL) that can transport fat molecules into artery walls, recruit macrophages, and thus 
drive atherosclerosis; in contrast, high-density lipoprotein (HDL) prevents or even 
reverses this process through removing fat molecules from macrophages in the artery 
walls [183]. 
The etiology of atherosclerosis is very complicated. Epidemiological studies over the past 
60 years have revealed that numerous risk factors for atherosclerosis. These factors can 
be clarified into factors with an important genetic component, and those that are largely 
related to environment. Men below 60 years old develop cardiovascular diseases 
including atherosclerosis at more than twice the rate of women under 60 years old [184]. 
When all known risk factors are controlled for, family history remains a crucial 
independent factor for atherosclerosis [185]. In addition, other health conditions, e.g. 
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hypertension, metabolic syndrome, systemic inflammation and depression, may 
contribute to the development of atherosclerosis [9]. 
The importance of environment in human atherosclerosis has been examined in twin 
studies. Population migration studies clearly show that the environmental factors explain 
much of the variation in atherosclerosis incidence between populations [186]. High-fat 
and high-cholesterol diets appear to be the most significant factor and are usually 
required for development of atherosclerosis in experimental animals [42]. Numerous 
epidemiological studies have strongly supported the association of smoking with the 
development of atherosclerosis; clinical trials have demonstrated the beneficial effects of 
stopping smoking [42]. Other environmental factors, e.g. lack of exercise, infectious 
agents and low antioxidant levels, may contribute to the development of atherosclerosis 
as well [9]. 
Substantial epidemiological studies have demonstrated long-term PM2.5 exposure as 
another risk factor for atherosclerosis in humans [187-189]. Subsequent animal studies 
have now corroborated these findings using “whole body PM2.5 exposure system”. Sun et 
al., reported that long-term PM2.5 exposure (6 hour a day, 5 days a week for 6 months) in 
conjunction with high-fat chow accelerated plaque development and increased vascular 
inflammation in an apolipoprotein (apo) E
-/-
 mice [28]. PM2.5 exposure can induce 
inflammation and oxidative stress within lungs and then release inflammatory mediators 
into circulation; these mediators thereafter convey an inflammatory signal to the 
vasculature, causing vasomotor dysfunction and chronically promoting atherosclerosis 
[31, 190].  
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ApoE
-/-
 mice and LDL receptor (LDLR)
-/-
 mice are the most common animal models for 
atherosclerosis. ApoE
-/-
 mice, first introduced in 1992, exhibit five times normal serum 
cholesterol and develop spontaneous atherosclerotic lesions [196-198], while LDLR
-/-
 
mice develop atherosclerosis with the assistance of dietary cholesterol. In addition, the 
atherosclerotic lesions in apoE
-/-
 mice are primarily composed of cholesterol clefts, while 
those in LDLR
-/-
 mice are primarily composed of foam cells [2]. Existing studies have 
confirmed that apoE
-/-
 mice are suitable model to investigate molecular basis of PM2.5-
mediated atherosclerosis [28, 174, 199]. This study was designed to evaluate 
atherosclerosis and identify key inflammatory mediators in response to long-term PM2.5 
exposure in apoE
-/-
 mice. 
Material and Methods 
Animal Model 
Six-week-old apoE
-/-
 male mice were purchased from the Jackson Laboratory (Bar 
Harbor, ME). All mice were maintained at 21 °C on a 12-h light/12-h dark cycle with free 
access to water and food. They were fed with 42% high-fat chow (n = 8; Adjusted 
Calories Diet, TD 88137, Harlan, Indianapolis, Ind); body weights and food consumption 
were monitored weekly. The Ohio State University Animal Care and Use Committee 
approved the protocols and the use of animals.  
Exposure Protocol 
Mice were exposed to either filtered air (FA) or concentrated ambient particles (CAPs) 
via our exposure system “Ohio Air Pollution Exposure System for Interrogation of 
Systemic Effects (OASIS)”, which was previously described. Mice were exposed for 6 
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hours per day, 5 days per week for a total of 6 months. Exposure began on March, 2012 
and was stopped on September, 2012. PM2.5 collection, gravimetric and elemental 
analyses were previously described in chapter 5. 
Morphometric Analysis 
The abdominal aorta was fixed in 10% zinc formalin and embedded in paraffin for 
hematoxylin-eosin (H & E) staining. Segments of thoracic aorta were frozen in liquid 
nitrogen and embedded in Optimal Cutting Temperature compound (Tissue-Tek, Sakura 
Finetek USA Inc, Torrance, CA) for oil red-O staining. Plaque area and lipid content 
were evaluated via H & E positive areas of aortic arch and oil-red O positive areas of 
thoracic aorta, respectively. At least 10 sections from 3 consecutive slides per area per 
mouse (abdominal and thoracic aortas) were detected. Each image was digitized under a 
microscope (Zeiss Axioskop with Spot I digital camera, Jena, Germany) and analyzed by 
National Institutes of Health Image J software. Plaque and lipid areas were normalized 
for the cross-sectional vessel cavity area and expressed as a percentage value.  
Blood Lipid and Glucose 
In the end of exposure, mouse was fasting overnight and the blood was obtained from the 
tip of the tail. Glucose levels were determined using a Contour Blood Glucose Meter 
(Bayer, Mishawaka, IN). After the exposure, mice were sacrificed after blood collection 
directly from left ventricle puncture. Blood samples were centrifuged at 3000 rpm for 5 
minutes and serum was separated. Total cholesterol and HDL levels were assayed using 
diagnostic kits (Thermo Electron, Louisville, CO).  
Plasma Levels of Inflammatory Cytokines 
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Whole blood was collected into EDTA-treated tubes. Cells were removed from plasma 
by centrifugation for 10 minutes at 2000 rpm using a refrigerated centrifuge. Following 
centrifugation, plasma (the liquid component) was transferred into a clean polypropylene 
tube using a Pasteur pipette. Plasma levels for tumor necrosis factor (TNF)-α, interferon 
(IFN)-γ, monocyte chemoattractant protein-1, interleukin (IL)-6 and -12, and adiponectin 
were detected using Mix-N-Match ELISArray Kit (Qiagen, Austin, TX) according to 
manufacturer instructions. 
Quantitative RT-PCR 
Lung was removed and homogenized by TRIzol Reagent (Invitrogen, Carlsbad, CA. 
Total RNA was then converted into cDNA with M-MLV Reverse Transcriptase enzyme 
(Invitrogen, Carlsbad, CA). Gene expression for TNF-α, MCP-1, IL-6 and -10 were 
determined using inventoried primer and probe assays (Applied Biosystems, Foster City, 
CA) on an ABI 7500 Fast Real Time PCR System using Taqman Universal PCR Master 
Mix. All reactions were performed under the following conditions: 50 °C for 2 minutes, 
95 °C for 10 minutes, 40 cycles of 95 °C for 15 seconds, and 60 °C for 1 minute. All data 
were standardized for β-actin and represented as relative mRNA expression. The primers 
are shown in table 4. 
Statistical Analyses 
Data were presented as mean ± S.D. unless otherwise stated. Unpaired student t-tests 
(two-sided) were performed using Prism 4.0 (GraphPad Software, San Diego, CA). In all 
cases, a p value less than 0.05 was considered to be statistically significant. 
Results  
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PM2.5 Characteristics during the Study Period 
The mean daily PM2.5 concentration at the study site in Columbus, OH, was 9.9 μg/m
3 
during the exposure. The average PM2.5 concentrations in FA and CAPs were 2.5 μg/m
3 
and 109.6 μg/m3, respectively. The average chemical composition of CAPs during the 
exposure period was summarized in table 5. As shown, the CAPs constituents were 
dominated by sulfate, which is typical for the study site. The results from the 
epidemiologic and toxicologic studies with PM sulfate are inconsistent and fail to support 
for a causal association of PM sulfate and health risk [195]. This indicates that sulfate in 
PM may affect health-related outcomes indirectly via interaction with certain metal 
species or secondary organic matter.  
Body Weight and Food Consumption 
Mice between FA and CAPs groups had similar body weights in the beginning of the 
study (Fig.9A), while after 6-month exposure, mice exposed to CAPs appeared to gain 
less body weights compared with those exposed to FA (Fig.9B). This was further 
confirmed by our data showing that mice exposed to CAPs consumed less food compared 
with those exposed to FA (Fig.9C). Our data indicate that long-term PM2.5 exposure may 
affect animal appetite and metabolism.  
PM2.5 Induced Atherosclerosis 
Fig.10 provided representative sections from morphometric analyses of the aorta and 
quantitated column bars. H & E staining showed that plaque area of the aorta was 
significantly increased in mice exposed to CAPs compared with those exposed to FA, 
while lipid area of the aorta detected by oil-red O staining was similar between two 
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groups. Our data indicate that long-term PM2.5 exposure potentiates atherosclerosis in an 
apoE
-/-
 mouse model, which verifies the previous findings [28, 168].  
To further evaluate the PM2.5-mediated vascular effects, we detected the serum levels of 
cholesterol and HDL in exposed mice. Our results showed that PM2.5 exposure caused an 
increase in cholesterol level (p < 0.05), but a decrease in HDL level (p < 0.01) (Fig.11A-
B). Our data, together with previous evidence [194], indicate that long-term PM2.5 
exposure may induce atherosclerosis via changing the lipid profile in blood. 
Previous studies have shown that PM2.5 exposure can exaggerate insulin resistance in 
both genetic and diet-induced obese mouse models [196, 197]. It has become evident that 
high glucose can increase the cardiovascular risk and serve as a marker for 
atherosclerosis [198-200]. In our study, the mice exposed to CAPs exhibited higher 
fasting glucose level relative to those exposed to FA (Fig.11C). Collectively, our data 
strongly show that long-term PM2.5 exposure induces atherosclerosis and changes the 
levels of the lipids and glucose in blood. 
PM2.5 Induced Inflammation 
Inflammation is involved in the development of atherosclerosis and anti-inflammatory 
mediator therapy can slow atherosclerosis progression in both animal and human studies 
[201-203]. To evaluate PM2.5-mediated inflammation, plasma levels of inflammatory 
mediators, e.g. TNF-α, IFN-γ, MCP-1, IL-6, IL-12 and adiponectin, were measured via 
ELISA kits. The results showed that plasma levels of TNF-α and IL-6 were significantly 
elevated in mice exposed to CAPs, but not the others (Fig.12). Our data are consistent 
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with the previous studies showing that PM2.5 exposure can increase the plasma levels of 
TNF-α and IL-6 [194, 204].  
Pulmonary inflammation was also detected via measuring mRNA levels of TNF-α, MCP-
1, IL-6 and IL-10. We found that relative mRNA level of IL-6 in the lung tissue was 
apparently elevated after exposure to CPAs, while others showed no significant changes 
(Fig.13). Our data indicate that IL-6 plays a crucial role in PM2.5-mediated inflammation 
in both circulation and tissue.  
Discussion 
The present study demonstrated PM2.5-potentiated atherosclerotic plaques in apoE
-/-
 mice. 
In addition, long-term PM2.5 exposure caused the increases in total cholesterol and 
glucose level, but the decrease in HDL level in mice. Furthermore, this study found that 
TNF-α and IL-6 in plasma were elevated after long-term PM2.5 exposure; that mRNA 
expression of IL-6 within lung was upregulated in response to long-term PM2.5 exposure. 
Our data showed that long-term PM2.5 exposure significantly reduced the food intake 
compared with FA group; body weight gain in mice exposed to CAPs appeared to be less 
than those exposed to FA. This indicates that long-term PM2.5 exposure may change the 
appetite and metabolism. Our previous data showed that 5-week PM2.5 exposure can 
significantly increase the level of circulating leptin [196]. Leptin is a hormone secreted 
by adipose tissue that regulates energy balance by inhibiting hunger. Elevated leptin may 
inhibit the appetite and then reduce the food consumption in mice exposed to CAPs. 
Although these mice gain less body weights, they exhibit more severe metabolic 
disorders. In our study, the data suggested that the blood glucose in mice exposed to 
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CAPs was almost twice as that in FA groups. It has become evident that high glucose can 
increase the cardiovascular risk and serve as a marker for atherosclerosis [198-200].  
Morphological analyses suggested that long-term PM2.5 exposure significantly increased 
the atherosclerotic plaque area in an apoE
-/-
 mouse model, which verifies the previous 
findings [28, 168]. Our data also showed that PM2.5 exposure caused an increase in 
cholesterol level, but a decrease in HDL level. Cholesterol is an essential structural 
component of cell membrane and serves as a precursor for the synthesis of steroid 
hormones [205]. Although cholesterol is essential for all animal life (not bacteria), high 
level of cholesterol in the circulation is strongly associated with the progression of 
atherosclerosis [206, 207]. HDL is one of lipoproteins and prevents atherosclerosis 
through transporting fat molecules, e.g. cholesterol and triglycerides, out of artery walls 
[208, 209]. Several mechanisms may claim its protective effects. First, HDL can directly 
bind unesterified cholesterol and remove excess cholesterol from cells and extracellular 
tissues [14]. Second, HDL may reverse endothelial dysfunction and improve endothelial 
barrier integrity. Third, HDL carries an esterase known as serum paraoxonase that can 
degrade certain biologically active oxidized phospholipids [17]. The antioxidant 
properties of HDL inhibit LDL oxidation, thereby reducing the inflammation and 
attenuating the uptakes by macrophages.  
Inflammation has a prominent role in atherosclerosis and its complications. Circulating 
monocytes migrate into the intima in the presence of adhesion molecules and 
chemoattractant proteins. Once resident in the arterial intima, monocytes acquire the 
morphological characteristics of macrophages, undergoing a series of changes that lead 
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ultimately to foam cell formation [18]. Inflammatory mediators, e.g. TNF-α, IL-6 and 
IFN-γ, are crucial for activation of macrophages and foam cell formation. In the present 
study, our data suggested that long-term exposure to PM2.5 can upregulate mRNA 
expression of IL-6 within lung, and cause increases in circulating TNF-α and IL-6.  
TNF-α is a pro-inflammatory cytokine secreted by a variety of cells including adipocytes, 
macrophages, natural killer cells, T-cells and endothelial cells [210]. Elevated circulating 
TNF-α predicts vascular damage since it is associated with early atherosclerosis in 
middle-aged healthy men [211]. TNF-α induces vascular inflammation via activation of 
nuclear factor-κB, thereby releasing adhesion molecules (e.g. ICAM-1 and VCAM-1) 
and chemoattractant proteins (e.g. MCP-1) from endothelial cells and smooth muscle 
cells. Previous in vitro studies have suggested that TNF-α may promote platelet 
aggregation and ROS production primarily through activation of the arachidonic acid 
pathways [212, 213]. Thus, TNF-α is deeply involved in vascular inflammation and 
plaque formation, facilitating the development of atherosclerosis. 
IL-6 is a multifunctional cytokine that has both pro-inflammatory and anti-inflammatory 
properties, depending on locations [214]. In healthy subjects, IL-6 expression is highly 
regulated by a complex hormonal network related to glucocorticoid and catecholamine 
secretion [215]. After PM2.5 exposure, IL-6 level can be elevated and then trigger innate 
immune system via binding to toll-like receptors [31, 216]. Increased IL-6 is highly 
associated with metabolic and vascular diseases, such as obesity, type 2 diabetes, 
atherosclerosis [215]. IL-6 plays a crucial role in plaque development and destabilization 
via release of other cytokines, oxidation of LDL, stimulation of ROS production, and 
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activation of MCP-1 [217]. These effects explain clinical observation that elevated IL-6 
levels in coronary and systemic circulation are a risk factor for atherosclerosis. 
Taken together, this study provided compelling evidence supporting that long-term PM2.5 
exposure mediated atherosclerosis and changed lipid profile in apoE
-/-
 mice. In addition, 
we identified TNF-α and IL-6 as the key inflammatory mediators in this process. These 
findings lead us to explore the protective effects of anti-inflammation using natural 
nutrients such as strawberry on the development of atherosclerosis after long-term PM2.5 
exposure. 
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Table 4. Primers Used for RT-PCR. 
 
RT-PCR: real time-polymerase chain reaction, TNF-α: tumor necrosis factor-α, MCP-1: 
monocyte chemoattractant protein-1, IL-6: interleukin-6, IL-10: interleukin-10. 
  
Primer Forward oligonucleotides Reverse oligonucleotides 
TNF-α 5’-TCTCATGCACCACCATCAAGGACT-
3’ 
5’-TGACCACTCTCCCTTTGCAGAACT-
3’ 
MCP-1 5’-
TGCTGTCTCAGCCCAGATGCAGTTA-
3’ 
5’TACAGCTTCTTTGGGACACCTGCT-3’ 
IL-6 5’-
TGGCTAAGGACCAAGACCATCCAA-3’ 
5’-AACGCACTAGGTTTGCCGAGTAGA-
3’ 
IL-10 5’-TTGCTCTTGCACTACCAAAGCCAC-
3’ 
5’-
AGTAAGAGCAGGCAGCATAGCAGT-3’ 
β-actin 5’-
TGTGATGGTGGGAATGGGTCAGAA-3’ 
5’-TGTGGTGCCAGATCTTCTCCATGT-
3’ 
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Table 5. PM2.5 Concentration and Compositions Collected via OASIS, March-
September, 2012. 
PM2.5 OASIS  
FA AA CAPs 
Mass Concentration (μg/m3) 2.5 9.9 109.6 
Trace Element (ng/m
3
) 
S32 39.8 842.7 7821.8 
Ca44 76.6 73.9 669.6 
Na23 34.8 57.1 450.5 
Fe57 10.1 40.1 441.7 
K39 24.5 40.8 336.6 
Al27 20.4 24.9 197.4 
Mg24 8.2 17.5 190.2 
Zn66 5.6 9.9 84.8 
P31 5.6 9.1 63.7 
Cr52 6.7 3.1 13.6 
Ba137 0.6 2.5 26.9 
Pb208 2.5 2.8 22.5 
Cu63 1.4 2.3 23.4 
Mn55 0.2 1.7 18.3 
Ti47 0.1 0.7 8.9 
Se77 0.0 0.8 8.0 
Sb123 0.0 0.6 6.1 
As75 0.0 0.5 5.0 
Ni60 0.3 0.5 2.4 
Sr88 0.1 0.4 4.0 
Mo95 0.1 0.3 2.7 
Cd111 0.5 0.2 1.7 
V51 0.0 0.2 2.1 
Co59 0.1 0.2 0.7 
Rb85 0.0 0.0 0.6 
Ce140 0.0 0.0 0.4 
La139 0.0 0.0 0.3 
PM2.5: fine particulate matters; OASIS: “Ohio Air Pollution Exposure Systems for 
Interrogation of Systemic Effects”; FA: filtered air; AA: ambient air; CAPs: concentrated 
air particles. 
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Figure 9. Body Weights and Food Consumption. (A) The curves of body weights during 
the exposure. (B) The percentages of body weights gained during the exposure. (C) 
Cumulative food intakes during the exposure. FA: filtered air; and CAPs: concentrated 
ambient particles. *** p < 0.001 vs. FA group. 
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Figure 10. Development of Atherosclerotic Plaque after PM2.5 Exposure. (A) 
Representative images of H & E staining of abdominal aortic sections and Oil-red O 
staining of aortic arch sections. (B) Plaque area was analyzed from H & E staining. (C) 
Lipid area was analyzed from Oil-red O staining. H & E staining: hematoxylin-eosin 
staining; FA: filtered air; and CAPs: concentrated ambient particles. * p < 0.05 vs. FA 
group. 
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Figure 11. Serum Lipids and Glucose after PM2.5 Exposure. (A) The concentration of 
serum cholesterol. (B) The concentration of serum HDL. (C) The concentration of fasting 
glucose. HDL: high-density lipoprotein; FA: filtered air; and CAPs: concentrated ambient 
particles. * p < 0.05 vs. FA group; ** p < 0.01 vs. FA group; *** p < 0.001 vs. FA group 
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Figure 12. Plasma Levels of Inflammatory Cytokines after PM2.5 Exposure. (A) The 
concentration of plasma TNF-α. (B) The concentration of plasma IFN-γ. (C) The 
concentration of plasma MCP-1. (D) The concentration of plasma IL-6. (E) The 
concentration of plasma IL-12. (F) The concentration of plasma adiponectin. TNF: tumor 
necrosis factor; IFN: interferon; MCP: monocyte chemoattractant protein; IL: interleukin; 
FA: filtered air; and CAPs: concentrated ambient particles. * p < 0.05 vs. FA group; *** 
p < 0.001 vs. FA group. 
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Figure 13. Relative mRNA Levels in Lung Tissues after PM2.5 Exposure. (A) TNF-α 
mRNA level. (B) MCP-1 mRNA level. (C) IL-6 mRNA level. (D) IL-10 mRNA level. 
TNF: tumor necrosis factor; MCP: monocyte chemoattractant protein; IL: interleukin; 
FA: filtered air; and CAPs: concentrated ambient particles. * p < 0.05 vs. FA group. 
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Chapter 7: Effects of Freeze-dried Strawberry Supplementation on Atherosclerosis after 
Long-term PM2.5 Exposure in a Mouse Model 
 
Abstract 
Strawberry, a rich source of micronutrients and several bioactive phytochemicals, has 
been implicated in the prevention of cardiovascular diseases and metabolic syndromes. 
This study aimed to evaluate the effects of strawberries on PM2.5-mediated 
atherosclerosis and inflammation in apoE
-/-
 mice. These mice were fed with high fat 
chow with or without 10% freeze-dried strawberry powder. In the meantime, they were 
exposed to either filtered air or concentrated ambient particles for 6 months. After 
exposure, plaque areas and lipid areas were evaluated using H & E staining and Oil-red 
O, respectively. Serum lipids and plasma cytokines were measured via ELISA kits. 
Relative mRNA expressions in lung were quantitated using RT-PCR. Our results showed 
that strawberries can significantly improve lipid profile and reduce the inflammation, but 
failed to improve atherosclerosis after PM2.5 exposure. This indicates that other 
mechanistic pathways may play roles in PM2.5-mediated atherosclerosis and diminish the 
effects of strawberries. 
Background 
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Strawberries, a unique combination of several nutrients, phytochemicals and fiber, are a 
great source of B-vitamins, vitamin C, vitamin E, potassium, folic acid, carotenoids, and 
specific flavonoids, e.g. pelargonidin, quercetin, and catechin. Strawberries also contain 
significant amounts of ellagic acids, tannins, and phytosterols [119]. These polyphenols 
have diverse structure and functions, accounting for most of the health benefits of 
strawberries. Ellafic acids have shown to exert significant free radical scavenging and 
anti-proliferative effects in several experimental models [119]. Flavonoids present free 
radical scavenging activity as well as anti-inflammatory and vasodilatory functions [218]. 
Phytosterols are plant-derived sterols that have similar structure and function to 
cholesterol. Numerous clinical trials have reported that dietary phytosterols present 
cholesterol lowering effects [219]. 
Strawberry has been implicated in the prevention of cardiovascular diseases [118, 220, 
221], and metabolic syndromes [117, 146]. In a randomized double-blind controlled trial, 
6-week strawberry supplementation can substantially reduce lipid peroxidation and 
inflammation, and improve glycemic control and antioxidant status in subjects with type 
2 diabetes [220]. Another study carried out in diabetic subjects showed that just two 
weeks on a diet rich in flavonols exhibited a protective effect against oxidative DNA 
damage in lymphocytes [222]. In an in vitro study, strawberry extract inhibited platelet 
aggregation and decreased the levels of inflammatory mediators, e.g. sP-selectin, 
sCD40L and IL-1β, in human platelet-rich plasma [221]. Treatment of rabbit aortic rings 
with aqueous extract of freeze-dried strawberry powder produced a dose-dependent 
endothelial relaxation [223].  
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Phytochemicals in strawberries, including anthocyanins, ellagic acids, catechin, quercetin 
and kaempferol, may account for the observed cardio-protective effects in both clinical 
and experimental studies. It has been shown that anthocyanin treatment can upregulate 
endothelial nitric oxide synthase (eNOS) in bovine artery endothelial cells [224]. This 
indicates that strawberry phytochemicals may reverse endothelial dysfunction and inhibit 
the initiation of atherosclerosis since eNOS has a crucial role in maintaining 
cardiovascular homeostasis. Subsequent animal studies demonstrate that purified 
anthocyanins from strawberries added to drinking water can prevent the development of 
dyslipidemia and obesity in mice fed with a high-fat diet for 3 months [225, 226]. 
Antioxidant effects and inhibition of platelet aggregation have also been reported in other 
studies investigating phytochemicals, e.g. catechin, ellagic acid, kaempferol and 
quercetin, suggesting their potential roles in the prevention of atherosclerosis [119]. 
Emerging evidence from animal and in vitro cell culture studies supports the roles of 
strawberries in ameliorating obesity, inflammation, hypertension, and oxidative stress, 
which are the risk factors for cardiovascular diseases [119]. Our previous studies have 
demonstrated that long-term exposure to PM2.5 potentiates atherosclerosis through 
upregulating inflammatory mediators, e.g. TNF-α and IL-6, in apoE-/- mice. This study 
was designed to evaluate the effects of strawberries on PM2.5-mediated atherosclerosis 
and inflammation in these mice.  
Material and Methods 
Animal Model and Feeding Study 
75 
 
Six-week-old apoE
-/-
 male mice were purchased from the Jackson Laboratory [227]. All 
mice were maintained at 21 °C on a 12-h light/12-h dark cycle with free access to water 
and food. They were fed either with 42% high-fat chow (Adjusted Calories Diet, TD 
88137, Harlan, Indianapolis, Ind), or with high-fat chow with 10% freeze-dried 
strawberry. This diet was ingredient-matched to the high-fat chow except that the 100g of 
freeze-dried strawberry power replaced 100g of sucrose in the custom formulation. The 
freeze-dried strawberry powder was provided by the California Strawberry Commission. 
Body weights and food consumption were monitored weekly. The Ohio State University 
Animal Care and Use Committee approved the protocols and the use of animals.  
Exposure Protocol 
Mice were exposed to either filtered air (FA) or concentrated ambient particles (CAPs) 
via our exposure system “Ohio Air Pollution Exposure System for Interrogation of 
Systemic Effects (OASIS)”, which was previously described. Mice were exposed for 6 
hours per day, 5 days per week for a total of 6 months. Exposure began on March, 2012 
and was stopped on September, 2012. PM2.5 collection, gravimetric and elemental 
analyses were previously described in chapter 5. 
Morphometric Analysis 
The abdominal aorta was fixed in 10% zinc formalin and embedded in paraffin for 
hematoxylin-eosin (H & E) staining. Segments of thoracic aorta were frozen in liquid 
nitrogen and embedded in Optimal Cutting Temperature compound (Tissue-Tek, Sakura 
Finetek USA Inc, Torrance, CA) for oil red-O staining. Plaque area and lipid content 
were evaluated via H & E positive areas of aortic arch and oil-red O positive areas of 
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thoracic aorta, respectively. At least 10 sections from 3 consecutive slides per area per 
mouse (abdominal and thoracic aortas) were detected. Each image was digitized under a 
microscope (Zeiss Axioskop with Spot I digital camera, Jena, Germany) and analyzed by 
National Institutes of Health Image J software. Plaque and lipid areas were normalized 
for the cross-sectional vessel cavity area and expressed as a percentage value.  
Blood Lipid and Glucose 
In the end of exposure, mouse was fasting overnight and the blood was obtained from the 
tip of the tail. Glucose levels were determined using a Contour Blood Glucose Meter 
(Bayer, Mishawaka, IN). After the exposure, mice were sacrificed after blood collection 
directly from left ventricle puncture. Blood samples were centrifuged at 3000 rpm for 5 
minutes and serum was separated. Total cholesterol and HDL levels were assayed using 
diagnostic kits (Thermo Electron, Louisville, CO).  
Plasma Levels of Inflammatory Cytokines 
Whole blood was collected into EDTA-treated tubes. Cells were removed from plasma 
by centrifugation for 10 minutes at 2000 rpm using a refrigerated centrifuge. Following 
centrifugation, plasma (the liquid component) was transferred into a clean polypropylene 
tube using a Pasteur pipette. Plasma levels for tumor necrosis factor (TNF)-α, interferon 
(IFN)-γ, monocyte chemoattractant protein-1, interleukin (IL)-6 and -12, and adiponectin 
were detected using Mix-N-Match ELISArray Kit (Qiagen, Austin, TX) according to 
manufacturer instructions. 
Quantitative RT-PCR 
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Lung was removed and homogenized by TRIzol Reagent (Invitrogen, Carlsbad, CA. 
Total RNA was then converted into cDNA with M-MLV Reverse Transcriptase enzyme 
(Invitrogen, Carlsbad, CA). Gene expression for TNF-α, MCP-1, IL-6 and -10 were 
determined using inventoried primer and probe assays (Applied Biosystems, Foster City, 
CA) on an ABI 7500 Fast Real Time PCR System using Taqman Universal PCR Master 
Mix. All reactions were performed under the following conditions: 50 °C for 2 minutes, 
95 °C for 10 minutes, 40 cycles of 95 °C for 15 seconds, and 60 °C for 1 minute. All data 
were standardized for β-actin and represented as relative mRNA expression.  
Statistical Analyses 
Data were presented as mean ± S.D. unless otherwise noted. One-way ANOVA followed 
by Bonferroni’s post-hoc test was performed using Prism 4.0 (GraphPad Software, Inc, 
San Diego, CA). In all cases, a p value less than 0.05 was considered to be statistically 
significant. 
Results  
CAPs Characteristics, Body Weights and Food Consumption 
PM2.5 concentration and average chemical compositions of CAPs have previously 
summarized in table 5. The average PM2.5 concentration in FA and CAPs were 2.5 μg/m
3 
and 109.6 μg/m3, respectively. The CAPs constituents were dominated by sulfate. After 
6-month exposure, animals exposed to CAPs appeared to gain less body weights 
compared with those exposed to FA, in both high-fat chow and strawberry treatment 
groups (Fig.14A-B). PM2.5 exposure significantly reduced food intakes in mice fed with 
high-fat chow or strawberry diet (Fig.14C). 
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Effects of Strawberry Supplementation on PM2.5-mediated Atherosclerosis 
As previously described, long-term PM2.5 exposure potentiated atherosclerosis in apoE
-/-
 
mice. To test the effects of strawberry supplementation on PM2.5-mediated 
atherosclerosis, mice were fed with high-fat diet with 10% freeze-dried strawberry during 
the exposure. Our date showed that mice with strawberry supplementation exhibited 
similar plaque areas and lipid areas compared with those without strawberry 
supplementation after long-term exposure to CAPs (Fig.15A-C). It was demonstrated that 
long-term PM2.5 exposure can upregulate the levels of total cholesterol and glucose, and 
decrease the HDL level in blood (Fig.16A-C); strawberry supplementation, however, 
almost restored these molecules to normal levels after PM2.5 exposure (Fig.16A-C).  
Effects of Strawberry Supplementation on PM2.5-mediated Inflammation 
To detect the effects of strawberries on PM2.5-mediated Inflammation, plasma levels of 
cytokines and mRNA expression of cytokines in lung were determined. Exposure to 
CAPs can significantly increase the levels of TNF-α and IL-6 in plasma relative to 
exposure to FA; while strawberry supplementation can decrease IL-6 level but not TNF-α 
level in plasma after PM2.5 exposure (Fig.17A and D). In addition, strawberries can 
robustly increase the plasma levels of IFN-γ and adiponectin in response to long-term 
PM2.5 exposure (Fig.17B and F). There are no differences detected for MCP-1 and IL-12 
in plasma after PM2.5 exposure and strawberry supplementation (Fig.17C and E). 
In addition to the increase in plasma, mRNA level of IL-6 was also elevated in lung in 
response to PM2.5 exposure; strawberries almost restored its level to normal (Fig.18C). 
Compared with the group without strawberries, the supplementation significantly 
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increased IL-10 mRNA expression in lung after PM2.5 exposure (Fig.18D). But no 
differences were observed for TNF-α and MCP-1 mRNA expressions among these 
groups (Fig.18A and B). Our data verified the previous findings that strawberries had 
anti-inflammatory properties and changed cytokine profile [150, 228]. 
Discussion  
The present study demonstrated that strawberry supplementation improved serum lipid 
profile and reduced inflammation after long-term exposure to PM2.5. However, our data 
showed that strawberry supplementation appears to have no effects on PM2.5-potentiated 
atherosclerosis in apoE
-/-
 mice. These data must be fully considered when the protective 
effects of strawberries on atherosclerosis are mentioned in future studies. 
Previous studies showing that strawberry supplementation can improve lipid profile and 
glucose level are consistent with our findings [229, 230]. As previously discussed, 
elevated cholesterol and glucose levels in circulation can increase the cardiovascular risk 
[198-200, 206, 207]; while serum HDL can prevent atherosclerosis through removing 
cholesterol and triglycerides from artery walls [208, 209]. This indicates that strawberry 
supplementation may prevent cardiovascular diseases in mice.  
Inflammation has been implicated in the progression of atherosclerosis and inflammatory 
cytokines may be used as potential therapeutic targets for accelerated atherosclerosis. 
Anti-inflammatory properties of strawberry have been well documented and may play a 
role in the prevention of cardiovascular diseases [114, 119]. Indeed, our data support that 
strawberries can reduce PM2.5-mediated inflammation via downregulating pro-
inflammatory cytokines, e.g. IL-6, and upregulating anti-inflammatory mediators, e.g. 
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adiponectin and IL-10. Collectively, these data indicate that strawberries may prevent the 
development of atherosclerosis in experimental mice.  
Surprisingly, strawberry supplementation appeared to have no effects on PM2.5-
potentiated atherosclerosis, although it improved serum lipid profile and modulated the 
inflammatory responses after PM2.5 exposure. Morphological analyses showed that 
strawberry supplementation failed to reduce both plaque area and lipid area of 
atherosclerotic lesion. Several mechanisms may explain these results. First, multiple risk 
factors for atherosclerosis in our model may diminish the benefits of strawberries. Our 
study employed apoE
-/-
 mice to investigate the development of atherosclerosis. This 
mouse exhibits five times normal serum cholesterol and develops spontaneous 
atherosclerotic lesions [191-193]. To accelerate the development of atherosclerosis in 
mice, we fed them with 40% high-fat chow. It has been suggested that high-fat diet is the 
most significant factor for atherosclerosis [42]. Furthermore, the animals were exposed to 
concentrated PM2.5 for 6 months, which has been verified by our data as another 
environmental risk factor for atherosclerosis. Taken together, these risk factors may be 
too complicated and powerful to be recovered by strawberries. A modified model 
considering all these aspects will be needed to evaluate the benefits of strawberries on 
cardiovascular diseases. 
Second, although our data showed the anti-inflammatory effects of strawberries (e.g. 
downregulating IL-6 and upregulating adiponectin and IL-10), the supplementation did 
not change the level of TNF-α. TNF-α is one of the upstream cytokines that regulate 
systemic inflammation and induce atherosclerosis. In patients with systemic 
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inflammatory disorders, the antibody against TNF-α can reverse endothelial dysfunction 
and reduce vascular event rates [231]. In addition, our data showed that IFN-γ in plasma 
was elevated by strawberries in response to PM2.5 exposure. This mediator regulates both 
innate and adaptive immune responses and may have distinct roles at different stages of 
atherosclerosis [232]. During the early phases, it is generally thought that IFN-γ 
stimulates cell recruitment to the plaque and disrupts lipid development; while in the late 
phases, IFN-γ seems to be pro-apoptotic and therefore accelerates atherosclerosis 
progression [232]. These two key cytokines may hold central roles in PM2.5-mediated 
atherosclerosis. The underlying pathways related to TNF-α and IFN-γ will be further 
investigated to explore why strawberries fail to improve atherosclerotic lesions. 
Third, other mechanistic pathways may diminish the effects of strawberry 
supplementation on PM2.5-mediated atherosclerosis. Indeed, the general mechanistic 
pathways whereby PM2.5 exposure may promote atherosclerosis progression include 
systemic oxidative stress and inflammation, autonomic nervous system imbalance, and 
the toxic effects of soluble metals and organic compounds in PM2.5 [31]. Although 
strawberries may attenuate inflammation after long-term exposure to PM2.5, the 
disruption of autonomic nervous system and the direct toxicity of PM components may 
contribute to the development of atherosclerosis is our study. 
Taken together, our data indicate that strawberry supplementation can improve serum 
lipid profile and reduce inflammation in response to long-term PM2.5 exposure. However, 
the morphometric data show no effects of strawberry supplementation on PM2.5-mediated 
atherosclerosis. Future studies, which concentrate on TNF-α or IFN-γ signaling and other 
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mechanistic pathways of PM2.5-mediated atherosclerosis using modified models, will be 
critical to elucidate the effects of strawberry supplementation on this event. 
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Figure 14. Body Weights and Food Consumption. (A) The curves of body weights during 
the exposure. (B) The percentages of body weights gained during the exposure. (C) 
Cumulative food intakes during the exposure. FA: filtered air; and CAPs: concentrated 
ambient particles; FA & S: filtered air plus strawberry supplementation; CAPs & S: 
concentrated ambient particles plus strawberry supplementation. ** p < 0.01 vs. FA 
group. 
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Figure 15. Effects of Strawberries on Plaque Development after PM2.5 Exposure. (A) 
Representative images of H & E staining of abdominal aortic sections and Oil-red O 
staining of aortic arch sections. (B) Plaque area was analyzed from H & E staining. (C) 
Lipid area was analyzed from Oil-red O staining. H & E staining: hematoxylin-eosin 
staining; FA: filtered air; and CAPs: concentrated ambient particles; FA & S: filtered air 
plus strawberry supplementation; CAPs & S: concentrated ambient particles plus 
strawberry supplementation. * p < 0.05 vs. FA group. 
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Figure 16. Effects of Strawberries on Serum Lipids and Glucose after PM2.5 Exposure. 
(A) The concentration of serum cholesterol. (B) The concentration of serum HDL. (C) 
The concentration of fasting glucose. HDL: high-density lipoprotein; FA: filtered air; and 
CAPs: concentrated ambient particles; FA & S: filtered air plus strawberry 
supplementation; CAPs & S: concentrated ambient particles plus strawberry 
supplementation. * p < 0.05 vs. FA group; ** p < 0.01 vs. FA group. 
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Figure 17. Effects of Strawberries on Plasma Levels of Inflammatory Cytokines after 
PM2.5 Exposure. (A) The concentration of plasma TNF-α. (B) The concentration of 
plasma IFN-γ. (C) The concentration of plasma MCP-1. (D) The concentration of plasma 
IL-6. (E) The concentration of plasma IL-12. (F) The concentration of plasma 
adiponectin. TNF: tumor necrosis factor; IFN: interferon; MCP: monocyte 
chemoattractant protein; IL: interleukin; FA: filtered air; and CAPs: concentrated ambient 
particles; FA & S: filtered air plus strawberry supplementation; CAPs & S: concentrated 
ambient particles plus strawberry supplementation. ** p < 0.01 vs. FA group. 
 
87 
 
 
 
 
Figure 18. Effects of Strawberries on Relative mRNA Levels in Lung after PM2.5 
Exposure. (A) TNF-α mRNA level. (B) MCP-1 mRNA level. (C) IL-6 mRNA level. (D) 
IL-10 mRNA level. TNF: tumor necrosis factor; MCP: monocyte chemoattractant 
protein; IL: interleukin; FA: filtered air; and CAPs: concentrated ambient particles; FA & 
S: filtered air plus strawberry supplementation; CAPs & S: concentrated ambient 
particles plus strawberry supplementation.   * p < 0.05 vs. FA group. 
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Chapter 8: Conclusions and Future Studies 
 
This study demonstrates that our exposure system “OASIS” is suitable for monitoring the 
local PM2.5 levels. The data collected via this system reveal the annual level and seasonal 
trend of PM2.5 in Columbus, Ohio. Although there are some fluctuations, the levels of 
PM2.5 in Columbus are below EPA standards. In addition, our data indicate that black 
carbon could be used as another marker to monitor local air pollution. Future studies of 
tracking emission sources and determining chemical-specific toxicological responses will 
help clarify the relationship between the compositions of PM2.5 and human health effects. 
In addition, our data show that “OASIS” only concentrates the ambient PM2.5 without 
changing its chemical compositions, indicating that this system is reliable for mimicking 
the effects of air pollution in real world. Using genetic mouse model, this study provides 
compelling evidence supporting that long-term PM2.5 exposure potentiated 
atherosclerosis and changed the lipid profile. We also identified TNF-α and IL-6 as the 
key inflammatory mediators in this process. These findings lead us to explore the 
protective effects of anti-inflammation using natural nutrients such as strawberry on the 
development of atherosclerosis after long-term PM2.5 exposure. 
Our data indicate that strawberry supplementation can improve serum lipid profile and 
reduce inflammation in response to long-term PM2.5 exposure. However, the 
morphometric data show no effects of strawberry supplementation on PM2.5-mediated 
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atherosclerosis. To elucidate the underlying mechanisms, several future studies will be 
needed. First, a relative moderate model involving one or two risk factors for 
atherosclerosis will be used to investigate the benefits of strawberries on cardiovascular 
function. Second, the effects of strawberries on the key cytokines, e.g. TNF-α and IFN-γ, 
will be robustly evaluated in response to long-term exposure to PM2.5. Finally, other 
mechanistic pathways of PM2.5-mediated atherosclerosis will be evaluated to explore the 
potential of strawberries.  
The effects of cytokines on PM2.5-mediated atherosclerosis remain largely unknown. 
Since most of cytokines have a very short-half life in vivo, it will be significant to 
monitor the dynamics of cytokines at different time-points, thereby evaluating their 
effects on atherosclerosis development. Cytokine-mediated signaling pathways will also 
be detected in future studies, such as TNF-α-activated NF-κB pathways. In addition, 
other significant molecules involving in development of atherosclerosis will be detected 
after PM2.5 exposure. For instance, CD36, a fatty acid translocase, can bind to oxidized 
LDL and regulate LDL aggregation, contributing to atherosclerosis. Whether PM2.5 
exposure influences the level of this molecule remains unclear. Data generated from 
immunoblots or real time-PCR will be helpful to clarify this question. 
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